| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2BC11 H1-10 H2BC12L H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC19P H2BC12 | 1.04e-27 | 100 | 93 | 20 | GO:0030527 |
| GeneOntologyMolecularFunction | structural molecule activity | H2BC11 H1-10 H2BC12L H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CCN1 AEBP1 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC19P RPL4 RPL6 RPL7A H2BC12 | 2.08e-13 | 891 | 93 | 25 | GO:0005198 |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 5.83e-13 | 67 | 93 | 10 | GO:0031492 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | H1-10 CHD4 H1-8 TOX4 CTCF H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 HMGN4 | 1.82e-11 | 167 | 93 | 12 | GO:0031490 |
| GeneOntologyMolecularFunction | nucleosome binding | 2.93e-11 | 98 | 93 | 10 | GO:0031491 | |
| GeneOntologyMolecularFunction | chromatin binding | H1-10 NCOA6 L3MBTL2 ING2 KAT6A CHD4 POLR3G H1-8 TOX4 CTCF BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 TAF5 HMGN4 VCX | 1.51e-10 | 739 | 93 | 20 | GO:0003682 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | NOLC1 H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC19P H2BC12 | 3.96e-08 | 398 | 93 | 13 | GO:0046982 |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 2.48e-06 | 21 | 93 | 4 | GO:0061676 | |
| GeneOntologyMolecularFunction | protein dimerization activity | NOLC1 H2BC11 SP100 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC19P H2BC12 LRRFIP1 | 4.32e-04 | 1205 | 93 | 15 | GO:0046983 |
| GeneOntologyMolecularFunction | syntaxin binding | 7.31e-04 | 87 | 93 | 4 | GO:0019905 | |
| GeneOntologyMolecularFunction | transcription factor binding | NOLC1 NCOA6 SP100 KAT6A PSMC1 HMGB2 CHD4 RFC1 H2BC13 H2BC9 CTCF | 7.46e-04 | 753 | 93 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 7.56e-04 | 9 | 93 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 9.17e-04 | 41 | 93 | 3 | GO:0140463 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 1.15e-03 | 11 | 93 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 1.15e-03 | 11 | 93 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 1.15e-03 | 11 | 93 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 1.37e-03 | 12 | 93 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.56e-03 | 582 | 93 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | STAT family protein binding | 1.62e-03 | 13 | 93 | 2 | GO:0097677 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.17e-03 | 15 | 93 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.94e-03 | 303 | 93 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.62e-03 | 66 | 93 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.62e-03 | 66 | 93 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | SNARE binding | 3.76e-03 | 136 | 93 | 4 | GO:0000149 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | H2BC11 H1-10 KAT6A HMGB2 H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 | 1.08e-22 | 122 | 93 | 18 | GO:0006334 |
| GeneOntologyBiologicalProcess | nucleosome organization | H2BC11 H1-10 KAT6A HMGB2 H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 | 1.87e-21 | 142 | 93 | 18 | GO:0034728 |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | H2BC11 H1-10 KAT6A HMGB2 H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 TAF5 | 2.33e-18 | 249 | 93 | 19 | GO:0065004 |
| GeneOntologyBiologicalProcess | chromatin organization | H2BC11 H1-10 BRPF3 L3MBTL2 ARID4A ING2 KAT6A HMGB2 CHD4 INO80D H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CTCF BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 HMGN4 VCX | 1.49e-16 | 896 | 93 | 28 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H2BC11 H1-10 BRPF3 L3MBTL2 ARID4A ING2 KAT6A HMGB2 CHD4 INO80D H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CTCF BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 TAF5 HMGN4 VCX | 2.62e-16 | 999 | 93 | 29 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2BC11 H1-10 BRPF3 ARID4A ING2 KAT6A HMGB2 CHD4 INO80D H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CTCF BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 | 1.54e-15 | 741 | 93 | 25 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromosome condensation | 4.09e-11 | 48 | 93 | 8 | GO:0030261 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 1.29e-10 | 55 | 93 | 8 | GO:0045910 | |
| GeneOntologyBiologicalProcess | chromosome organization | H1-10 SP100 KAT6A GOLGA6C GOLGA6D HMGB2 GOLGA6B GOLGA6A RFC1 INO80D H1-8 CTCF H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 | 1.41e-09 | 686 | 93 | 18 | GO:0051276 |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 3.88e-09 | 30 | 93 | 6 | GO:0002227 | |
| GeneOntologyBiologicalProcess | mucosal immune response | 7.52e-08 | 48 | 93 | 6 | GO:0002385 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 1.55e-07 | 54 | 93 | 6 | GO:0002251 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 3.92e-07 | 150 | 93 | 8 | GO:0000018 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 4.19e-07 | 34 | 93 | 5 | GO:0008356 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA metabolic process | 5.03e-07 | 155 | 93 | 8 | GO:0051053 | |
| GeneOntologyBiologicalProcess | DNA recombination | 8.29e-07 | 368 | 93 | 11 | GO:0006310 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 1.13e-06 | 18 | 93 | 4 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 1.43e-06 | 19 | 93 | 4 | GO:0060050 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 2.34e-06 | 85 | 93 | 6 | GO:0019731 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 3.21e-06 | 23 | 93 | 4 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 3.84e-06 | 24 | 93 | 4 | GO:0060049 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 5.25e-06 | 150 | 93 | 7 | GO:0050830 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | H1-10 SP100 BRPF3 HMGB2 CHD4 RFC1 INO80D H1-8 TADA1 TBRG1 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 TAF5 | 5.93e-06 | 1081 | 93 | 17 | GO:0006259 |
| GeneOntologyBiologicalProcess | Golgi localization | 6.28e-06 | 27 | 93 | 4 | GO:0051645 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 7.30e-06 | 28 | 93 | 4 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 7.30e-06 | 28 | 93 | 4 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 7.30e-06 | 28 | 93 | 4 | GO:0048313 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | H1-10 BRPF3 INO80D H1-8 TADA1 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 TAF5 | 8.63e-06 | 564 | 93 | 12 | GO:0051052 |
| GeneOntologyBiologicalProcess | regulation of binding | SP100 GAS8 GOLGA6C DAB2 GOLGA6D HMGB2 GOLGA6B GOLGA6A BRD4 H1-0 | 1.19e-05 | 396 | 93 | 10 | GO:0051098 |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 2.04e-05 | 36 | 93 | 4 | GO:0010560 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 2.28e-05 | 37 | 93 | 4 | GO:0000212 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 3.13e-05 | 40 | 93 | 4 | GO:1903020 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 3.22e-05 | 134 | 93 | 6 | GO:0061844 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 1.18e-04 | 106 | 93 | 5 | GO:0032091 | |
| GeneOntologyBiologicalProcess | negative regulation of binding | 1.21e-04 | 170 | 93 | 6 | GO:0051100 | |
| GeneOntologyBiologicalProcess | male gonad development | 1.25e-04 | 171 | 93 | 6 | GO:0008584 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 1.27e-04 | 57 | 93 | 4 | GO:0007020 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 1.29e-04 | 172 | 93 | 6 | GO:0046546 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SP100 SFRP1 L3MBTL2 ARID4A ING2 KAT6A DAB2 HMGB2 CHD4 RFC1 AEBP1 CTCF H1-2 H1-3 H1-4 H1-5 LRRFIP1 | 1.54e-04 | 1399 | 93 | 17 | GO:0045892 |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.67e-04 | 114 | 93 | 5 | GO:0050772 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SP100 SFRP1 L3MBTL2 ARID4A ING2 KAT6A DAB2 HMGB2 CHD4 RFC1 AEBP1 CTCF H1-2 H1-3 H1-4 H1-5 LRRFIP1 | 1.74e-04 | 1413 | 93 | 17 | GO:1902679 |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 1.97e-04 | 186 | 93 | 6 | GO:0019730 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SP100 ARID4A ING2 DAB2 HMGB2 CHD4 RFC1 AEBP1 CTCF H1-2 H1-3 H1-4 H1-5 LRRFIP1 | 2.56e-04 | 1053 | 93 | 14 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 2.68e-04 | 69 | 93 | 4 | GO:0010559 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 2.84e-04 | 199 | 93 | 6 | GO:0046661 | |
| GeneOntologyBiologicalProcess | ribosomal large subunit biogenesis | 3.32e-04 | 73 | 93 | 4 | GO:0042273 | |
| GeneOntologyBiologicalProcess | ribosome assembly | 3.50e-04 | 74 | 93 | 4 | GO:0042255 | |
| GeneOntologyBiologicalProcess | cotranslational protein targeting to membrane | 4.00e-04 | 32 | 93 | 3 | GO:0006613 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 4.08e-04 | 77 | 93 | 4 | GO:0051289 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 4.71e-04 | 80 | 93 | 4 | GO:1903018 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 5.27e-04 | 515 | 93 | 9 | GO:0022613 | |
| GeneOntologyBiologicalProcess | post-translational protein targeting to membrane, translocation | 5.53e-04 | 8 | 93 | 2 | GO:0031204 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 5.85e-04 | 228 | 93 | 6 | GO:0043393 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 7.99e-04 | 92 | 93 | 4 | GO:0090307 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 8.17e-04 | 336 | 93 | 7 | GO:0042254 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | NOLC1 H2BC11 SP100 RAP1A AHI1 GAS8 SRP72 TULP1 TBRG1 CTCF SEC62 H1-5 SEC63 | 1.20e-03 | 1091 | 93 | 13 | GO:0033365 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 1.37e-03 | 475 | 93 | 8 | GO:0140694 | |
| GeneOntologyBiologicalProcess | translation at presynapse | 1.41e-03 | 49 | 93 | 3 | GO:0140236 | |
| GeneOntologyBiologicalProcess | translation at synapse | 1.49e-03 | 50 | 93 | 3 | GO:0140241 | |
| GeneOntologyBiologicalProcess | translation at postsynapse | 1.49e-03 | 50 | 93 | 3 | GO:0140242 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 1.66e-03 | 112 | 93 | 4 | GO:0010507 | |
| GeneOntologyBiologicalProcess | protein targeting to ER | 1.67e-03 | 52 | 93 | 3 | GO:0045047 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA binding | 1.67e-03 | 52 | 93 | 3 | GO:0043388 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.71e-03 | 113 | 93 | 4 | GO:0051262 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 1.77e-03 | 612 | 93 | 9 | GO:0010975 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 1.77e-03 | 53 | 93 | 3 | GO:1902041 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.78e-03 | 192 | 93 | 5 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of DNA binding | 1.83e-03 | 115 | 93 | 4 | GO:0051101 | |
| GeneOntologyBiologicalProcess | microtubule polymerization | 1.95e-03 | 117 | 93 | 4 | GO:0046785 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to endoplasmic reticulum | 2.07e-03 | 56 | 93 | 3 | GO:0072599 | |
| GeneOntologyBiologicalProcess | defense response to Gram-negative bacterium | 2.07e-03 | 119 | 93 | 4 | GO:0050829 | |
| GeneOntologyBiologicalProcess | gonad development | 2.08e-03 | 292 | 93 | 6 | GO:0008406 | |
| GeneOntologyCellularComponent | nucleosome | H2BC11 H1-10 KAT6A H2BC12L H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC19P H2BC12 | 1.36e-26 | 138 | 95 | 21 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | HNRNPDL H2BC11 H1-10 BRPF3 ARID4A ING2 KAT6A HMGB2 CHD4 INO80D H2BC12L H1-8 H2BC13 H2BC15 TOX4 TADA1 H2BC9 H2BC4 BBX H2BC17 H2BC21 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC19P TAF5 HMGN4 H2BC12 | 5.50e-16 | 1480 | 95 | 34 | GO:0000785 |
| GeneOntologyCellularComponent | euchromatin | 9.21e-07 | 72 | 95 | 6 | GO:0000791 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 1.48e-05 | 33 | 95 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum | 2.06e-04 | 64 | 95 | 4 | GO:0005791 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 4.23e-04 | 7 | 95 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 5.62e-04 | 8 | 95 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | cis-Golgi network | 6.12e-04 | 85 | 95 | 4 | GO:0005801 | |
| GeneOntologyCellularComponent | granular component | 7.21e-04 | 9 | 95 | 2 | GO:0001652 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 8.93e-04 | 94 | 95 | 4 | GO:0032580 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 8.93e-04 | 94 | 95 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.30e-03 | 104 | 95 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.55e-03 | 109 | 95 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.60e-03 | 110 | 95 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | cytosolic large ribosomal subunit | 2.46e-03 | 59 | 95 | 3 | GO:0022625 | |
| MousePheno | increased alveolar macrophage number | 3.18e-07 | 14 | 61 | 4 | MP:0014228 | |
| MousePheno | abnormal alveolar macrophage number | 4.32e-07 | 15 | 61 | 4 | MP:0014227 | |
| MousePheno | abnormal Golgi vesicle transport | 2.26e-06 | 22 | 61 | 4 | MP:0030949 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 3.27e-06 | 24 | 61 | 4 | MP:0031355 | |
| MousePheno | abnormal alveolar macrophage morphology | 5.34e-06 | 27 | 61 | 4 | MP:0008245 | |
| MousePheno | immotile sperm | 5.59e-06 | 59 | 61 | 5 | MP:0020869 | |
| MousePheno | absent sperm mitochondrial sheath | 6.21e-06 | 28 | 61 | 4 | MP:0009833 | |
| MousePheno | abnormal hepatocyte morphology | 7.47e-06 | 166 | 61 | 7 | MP:0000607 | |
| MousePheno | absent acrosome | 1.08e-05 | 32 | 61 | 4 | MP:0008839 | |
| MousePheno | abnormal Golgi apparatus morphology | 1.22e-05 | 33 | 61 | 4 | MP:0011743 | |
| MousePheno | abnormal actin cytoskeleton morphology | 1.38e-05 | 34 | 61 | 4 | MP:0020849 | |
| MousePheno | abnormal sperm nucleus morphology | 1.71e-05 | 74 | 61 | 5 | MP:0009232 | |
| MousePheno | globozoospermia | 1.71e-05 | 74 | 61 | 5 | MP:0002686 | |
| MousePheno | abnormal pulmonary alveolus epithelium morphology | 2.50e-05 | 80 | 61 | 5 | MP:0010898 | |
| MousePheno | abnormal microtubule cytoskeleton morphology | 4.67e-05 | 46 | 61 | 4 | MP:0020850 | |
| MousePheno | abnormal acrosome assembly | 4.92e-05 | 92 | 61 | 5 | MP:0031354 | |
| MousePheno | abnormal liver lobule morphology | 5.94e-05 | 229 | 61 | 7 | MP:0008987 | |
| MousePheno | abnormal acrosome morphology | 6.53e-05 | 159 | 61 | 6 | MP:0008898 | |
| MousePheno | pulmonary fibrosis | 7.03e-05 | 51 | 61 | 4 | MP:0006050 | |
| MousePheno | abnormal liver parenchyma morphology | 8.63e-05 | 243 | 61 | 7 | MP:0008986 | |
| MousePheno | increased Harderian gland adenoma incidence | 1.12e-04 | 4 | 61 | 2 | MP:0013538 | |
| MousePheno | abnormal surfactant physiology | 1.17e-04 | 58 | 61 | 4 | MP:0004782 | |
| MousePheno | embryonic lethality prior to organogenesis | DHX37 DAB2 GEMIN5 CHD4 RFC1 POLR3G PPP1R8 TADA1 CTCF BRD4 SEC62 TAF5 SEC63 DDX24 METAP2 | 1.55e-04 | 1204 | 61 | 15 | MP:0013292 |
| MousePheno | abnormal lung epithelium morphology | 1.61e-04 | 118 | 61 | 5 | MP:0006382 | |
| MousePheno | abnormal type II pneumocyte morphology | 2.05e-04 | 67 | 61 | 4 | MP:0002275 | |
| MousePheno | decreased Purkinje cell number | 2.05e-04 | 67 | 61 | 4 | MP:0000880 | |
| MousePheno | decreased neuron number | 2.15e-04 | 376 | 61 | 8 | MP:0008948 | |
| MousePheno | abnormal preimplantation embryo morphology | 2.22e-04 | 283 | 61 | 7 | MP:0014137 | |
| MousePheno | abnormal Purkinje cell number | 2.29e-04 | 69 | 61 | 4 | MP:0000878 | |
| MousePheno | small proamniotic cavity | 2.78e-04 | 6 | 61 | 2 | MP:0011208 | |
| MousePheno | increased Harderian gland tumor incidence | 2.78e-04 | 6 | 61 | 2 | MP:0012437 | |
| MousePheno | abnormal cell cytoskeleton morphology | 3.16e-04 | 75 | 61 | 4 | MP:0020378 | |
| MousePheno | abnormal pulmonary alveolus epithelial cell morphology | 3.50e-04 | 77 | 61 | 4 | MP:0002273 | |
| MousePheno | liver fibrosis | 3.50e-04 | 77 | 61 | 4 | MP:0003333 | |
| MousePheno | abnormal respiratory epithelium morphology | 5.43e-04 | 235 | 61 | 6 | MP:0010942 | |
| MousePheno | abnormal spermiogenesis | 5.68e-04 | 237 | 61 | 6 | MP:0001932 | |
| MousePheno | abnormal pulmonary alveolar parenchyma morphology | 6.34e-04 | 90 | 61 | 4 | MP:0010901 | |
| MousePheno | embryonic lethality prior to tooth bud stage | DHX37 DAB2 GEMIN5 CHD4 RFC1 POLR3G PPP1R8 TADA1 CTCF BRD4 SEC62 TAF5 SEC63 DDX24 METAP2 | 6.96e-04 | 1383 | 61 | 15 | MP:0013293 |
| MousePheno | abnormal sperm mitochondrial sheath morphology | 7.77e-04 | 95 | 61 | 4 | MP:0009832 | |
| MousePheno | abnormal neuron number | 7.79e-04 | 456 | 61 | 8 | MP:0008946 | |
| MousePheno | abnormal pulmonary alveolus morphology | 8.33e-04 | 255 | 61 | 6 | MP:0002270 | |
| MousePheno | abnormal blastocyst morphology | 9.03e-04 | 259 | 61 | 6 | MP:0004957 | |
| MousePheno | abnormal sperm head morphology | 9.40e-04 | 261 | 61 | 6 | MP:0009230 | |
| MousePheno | decreased sperm progressive motility | 9.41e-04 | 100 | 61 | 4 | MP:0020451 | |
| MousePheno | asthenozoospermia | 9.66e-04 | 362 | 61 | 7 | MP:0002675 | |
| MousePheno | abnormal sperm progressive motility | 9.77e-04 | 101 | 61 | 4 | MP:0020450 | |
| MousePheno | abnormal cerebellar layer morphology | 9.78e-04 | 263 | 61 | 6 | MP:0009956 | |
| MousePheno | ataxia | 1.04e-03 | 266 | 61 | 6 | MP:0001393 | |
| MousePheno | abnormal pulmonary acinus morphology | 1.45e-03 | 284 | 61 | 6 | MP:0010911 | |
| MousePheno | abnormal sperm motility | 1.74e-03 | 401 | 61 | 7 | MP:0002674 | |
| MousePheno | abnormal sperm flagellum morphology | 1.76e-03 | 295 | 61 | 6 | MP:0008892 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 1.79e-03 | 296 | 61 | 6 | MP:0010899 | |
| MousePheno | abnormal cerebellar cortex morphology | 1.92e-03 | 300 | 61 | 6 | MP:0004097 | |
| MousePheno | teratozoospermia | 1.92e-03 | 408 | 61 | 7 | MP:0005578 | |
| MousePheno | abnormal Purkinje cell morphology | 1.93e-03 | 204 | 61 | 5 | MP:0000877 | |
| MousePheno | slow postnatal weight gain | 1.97e-03 | 205 | 61 | 5 | MP:0008489 | |
| Domain | H2B | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 3.15e-23 | 21 | 93 | 12 | SM00427 |
| Domain | HISTONE_H2B | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 3.15e-23 | 21 | 93 | 12 | PS00357 |
| Domain | Histone_H2B | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 3.15e-23 | 21 | 93 | 12 | IPR000558 |
| Domain | H15 | 8.90e-19 | 13 | 93 | 9 | SM00526 | |
| Domain | H15 | 8.90e-19 | 13 | 93 | 9 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 2.48e-18 | 14 | 93 | 9 | IPR005818 | |
| Domain | Histone | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 5.20e-17 | 56 | 93 | 12 | PF00125 |
| Domain | Histone_H2A/H2B/H3 | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 5.20e-17 | 56 | 93 | 12 | IPR007125 |
| Domain | Linker_histone | 3.50e-16 | 13 | 93 | 8 | PF00538 | |
| Domain | Histone_H5 | 4.80e-16 | 8 | 93 | 7 | IPR005819 | |
| Domain | Histone-fold | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 8.09e-15 | 83 | 93 | 12 | IPR009072 |
| Domain | - | 5.62e-11 | 69 | 93 | 9 | 1.10.20.10 | |
| Domain | VCX/VCY1 | 2.87e-09 | 5 | 93 | 4 | IPR026653 | |
| Domain | VCX_VCY | 2.87e-09 | 5 | 93 | 4 | PF15231 | |
| Domain | - | 1.12e-08 | 218 | 93 | 11 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 3.30e-08 | 242 | 93 | 11 | IPR011991 | |
| Domain | GOLGA2L5 | 1.67e-06 | 18 | 93 | 4 | PF15070 | |
| Domain | Golgin_A | 1.67e-06 | 18 | 93 | 4 | IPR024858 | |
| Domain | HMG_box_dom | 1.79e-05 | 65 | 93 | 5 | IPR009071 | |
| Domain | HMG_box | 1.40e-04 | 53 | 93 | 4 | PF00505 | |
| Domain | HMG_BOX_2 | 1.51e-04 | 54 | 93 | 4 | PS50118 | |
| Domain | HMG | 1.51e-04 | 54 | 93 | 4 | SM00398 | |
| Domain | - | 1.62e-04 | 55 | 93 | 4 | 1.10.30.10 | |
| Domain | PHD | 5.34e-04 | 75 | 93 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 6.51e-04 | 79 | 93 | 4 | IPR019787 | |
| Domain | HMG_box_2 | 8.63e-04 | 9 | 93 | 2 | PF09011 | |
| Domain | PHD | 1.02e-03 | 89 | 93 | 4 | SM00249 | |
| Domain | Znf_PHD | 1.11e-03 | 91 | 93 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.30e-03 | 95 | 93 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.35e-03 | 96 | 93 | 4 | PS01359 | |
| Domain | Zinc_finger_PHD-type_CS | 4.18e-03 | 65 | 93 | 3 | IPR019786 | |
| Domain | Znf_FYVE_PHD | 6.26e-03 | 147 | 93 | 4 | IPR011011 | |
| Domain | Bromodomain_CS | 7.38e-03 | 26 | 93 | 2 | IPR018359 | |
| Domain | LisH | 8.52e-03 | 28 | 93 | 2 | SM00667 | |
| Domain | LisH | 8.52e-03 | 28 | 93 | 2 | IPR006594 | |
| Domain | LISH | 8.52e-03 | 28 | 93 | 2 | PS50896 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC12 | 5.29e-24 | 79 | 70 | 17 | M27191 |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC11 H2BC12L H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.20e-19 | 42 | 70 | 12 | M48029 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC12 | 6.07e-17 | 197 | 70 | 17 | M27188 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2BC11 CHD4 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.71e-15 | 75 | 70 | 12 | M27343 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.00e-15 | 55 | 70 | 11 | M29526 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.29e-15 | 62 | 70 | 11 | M27700 |
| Pathway | REACTOME_DNA_METHYLATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.20e-14 | 64 | 70 | 11 | M27429 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2BC11 RFC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.69e-14 | 90 | 70 | 12 | M2158 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.72e-14 | 66 | 70 | 11 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.06e-14 | 67 | 70 | 11 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.06e-14 | 67 | 70 | 11 | M39003 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.44e-14 | 68 | 70 | 11 | M27658 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.44e-14 | 68 | 70 | 11 | M27587 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2BC11 NCOA6 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CTCF H2BC5 H2BC3 H2BC12 | 2.49e-14 | 122 | 70 | 13 | M29689 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 ARID4A CHD4 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.90e-14 | 94 | 70 | 12 | M27230 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.42e-14 | 70 | 70 | 11 | M48261 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.42e-14 | 70 | 70 | 11 | M48028 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2BC11 CHD4 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.28e-14 | 97 | 70 | 12 | M48262 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.74e-14 | 72 | 70 | 11 | M29714 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.74e-14 | 72 | 70 | 11 | M27132 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.56e-14 | 73 | 70 | 11 | M27166 |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 9.17e-14 | 13 | 70 | 7 | M1018 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 9.40e-14 | 54 | 70 | 10 | MM14904 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 CHD4 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.14e-13 | 105 | 70 | 12 | M27425 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.19e-13 | 78 | 70 | 11 | M1061 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.19e-13 | 78 | 70 | 11 | M27589 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2BC11 CHD4 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.43e-13 | 107 | 70 | 12 | M48260 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 BRPF3 KAT6A H2BC13 H2BC15 TADA1 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.83e-13 | 142 | 70 | 13 | M27233 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2BC11 CHD4 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.01e-13 | 110 | 70 | 12 | M27696 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2BC11 RFC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.51e-13 | 112 | 70 | 12 | M4052 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.72e-13 | 88 | 70 | 11 | M1011 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.37e-13 | 89 | 70 | 11 | M27943 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.09e-13 | 90 | 70 | 11 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.09e-13 | 90 | 70 | 11 | M29668 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.90e-13 | 91 | 70 | 11 | M27101 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.82e-13 | 93 | 70 | 11 | M27487 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.95e-13 | 94 | 70 | 11 | M1080 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.26e-12 | 96 | 70 | 11 | M27792 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 H2BC12L H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.27e-12 | 128 | 70 | 12 | M48019 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.39e-12 | 129 | 70 | 12 | M27795 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.42e-12 | 97 | 70 | 11 | M27590 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.09e-12 | 104 | 70 | 11 | M29829 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2BC11 RFC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.41e-12 | 139 | 70 | 12 | M868 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 BRPF3 ARID4A KAT6A CHD4 H2BC13 H2BC15 TADA1 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.63e-12 | 272 | 70 | 15 | M29619 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC11 RFC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.72e-12 | 140 | 70 | 12 | M27584 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.83e-12 | 106 | 70 | 11 | M27458 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2BC11 CHD4 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.40e-12 | 142 | 70 | 12 | M48257 |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.71e-12 | 108 | 70 | 11 | M27426 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.78e-12 | 110 | 70 | 11 | M27958 |
| Pathway | REACTOME_DNA_REPLICATION | H2BC11 PSMC1 RFC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.35e-12 | 187 | 70 | 13 | M1017 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.39e-12 | 111 | 70 | 11 | M27187 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.06e-12 | 112 | 70 | 11 | M48334 |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 1.09e-11 | 12 | 70 | 6 | MM14554 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 1.11e-11 | 59 | 70 | 9 | M27763 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.38e-11 | 119 | 70 | 11 | M607 |
| Pathway | REACTOME_MEIOSIS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.51e-11 | 120 | 70 | 11 | M529 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.69e-11 | 159 | 70 | 12 | M27665 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.37e-11 | 125 | 70 | 11 | M27186 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.01e-11 | 167 | 70 | 12 | M19381 |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | H2BC11 NCOA6 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 RPL4 RPL6 RPL7A H2BC12 | 3.64e-11 | 828 | 70 | 22 | M27827 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC11 RFC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.72e-11 | 170 | 70 | 12 | M27582 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 5.50e-11 | 46 | 70 | 8 | MM14935 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.57e-11 | 139 | 70 | 11 | M715 |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.55e-11 | 142 | 70 | 11 | M27660 |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2BC11 SFRP1 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.01e-10 | 233 | 70 | 13 | M27099 |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 1.43e-10 | 17 | 70 | 6 | M27189 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.61e-10 | 149 | 70 | 11 | M27888 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 1.68e-10 | 79 | 70 | 9 | M27742 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 2.48e-10 | 55 | 70 | 8 | MM14932 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.52e-10 | 116 | 70 | 10 | M29806 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2BC11 NCOA6 CHD4 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.96e-10 | 254 | 70 | 13 | M27131 |
| Pathway | REACTOME_REPRODUCTION | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.03e-10 | 158 | 70 | 11 | M26956 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 3.25e-10 | 119 | 70 | 10 | MM14901 | |
| Pathway | REACTOME_DNA_REPAIR | H2BC11 TRIM25 RFC1 INO80D H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.23e-10 | 332 | 70 | 14 | M15434 |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | H2BC11 TRIM25 ARID4A PSMC1 GEMIN5 CHD4 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H2BC5 H2BC3 TAF5 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 9.70e-10 | 888 | 70 | 21 | M48034 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.40e-09 | 138 | 70 | 10 | M29805 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.50e-09 | 139 | 70 | 10 | M4741 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.74e-09 | 237 | 70 | 12 | M27786 |
| Pathway | REACTOME_DEUBIQUITINATION | H2BC11 TRIM25 PSMC1 INO80D H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.18e-09 | 299 | 70 | 13 | M27574 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.65e-09 | 246 | 70 | 12 | M10189 |
| Pathway | REACTOME_MITOTIC_PROPHASE | GOLGA6C GOLGA6D GOLGA6B GOLGA6A H2BC13 H2BC15 H2BC9 H2BC5 H2BC3 | 4.63e-09 | 114 | 70 | 9 | MM15361 |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 6.13e-09 | 52 | 70 | 7 | M2341 | |
| Pathway | REACTOME_HCMV_INFECTION | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.67e-09 | 162 | 70 | 10 | M29804 |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2BC11 SFRP1 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.16e-09 | 330 | 70 | 13 | M7847 |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 7.54e-09 | 15 | 70 | 5 | MM14902 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.01e-08 | 220 | 70 | 11 | M27794 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2BC11 PSMC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.05e-08 | 221 | 70 | 11 | M27578 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 BRPF3 ARID4A KAT6A CHD4 H2BC13 H2BC15 H2BC9 H2BC5 H2BC3 | 1.40e-08 | 175 | 70 | 10 | MM14941 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.75e-08 | 291 | 70 | 12 | M16647 |
| Pathway | REACTOME_INFECTIOUS_DISEASE | H2BC11 TRIM25 ARID4A PSMC1 GEMIN5 CHD4 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H2BC5 H2BC3 TAF5 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 3.19e-08 | 1081 | 70 | 21 | M27548 |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.42e-07 | 49 | 70 | 6 | MM15448 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.09e-07 | 296 | 70 | 11 | M27869 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 4.01e-07 | 31 | 70 | 5 | MM17225 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.00e-07 | 323 | 70 | 11 | M27080 |
| Pathway | REACTOME_M_PHASE | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.63e-07 | 417 | 70 | 12 | M27662 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 9.47e-07 | 67 | 70 | 6 | MM15429 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 1.01e-06 | 37 | 70 | 5 | MM14883 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 1.15e-06 | 38 | 70 | 5 | MM15434 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 1.32e-06 | 39 | 70 | 5 | MM14850 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 1.71e-06 | 74 | 70 | 6 | MM14605 | |
| Pubmed | H2BC11 H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC20P H2BC19P H2BC12 | 3.43e-30 | 77 | 98 | 18 | 12408966 | |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 2.28e-27 | 18 | 98 | 12 | 16283522 |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 2.28e-27 | 18 | 98 | 12 | 12757711 |
| Pubmed | HNRNPDL NOLC1 H2BC11 SP100 RAP1A GOLGA6C GOLGA6D SRP72 HMGB2 GOLGA6B CHD4 GOLGA6A H2BC13 H2BC15 H2BC9 BBX H2BC17 H2BC21 TMA7 SEC62 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 TMPRSS7 SPAG17 KIAA2012 HMGN4 RPL4 RPL6 RPL7A H2BC12 | 7.52e-25 | 1442 | 98 | 36 | 35575683 | |
| Pubmed | HNRNPDL H2BC11 H1-10 TRIM25 PSMC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 SURF6 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 1.29e-24 | 425 | 98 | 24 | 21081503 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HNRNPDL NOLC1 H1-10 NCOA6 L3MBTL2 ARID4A ING2 CHD4 RFC1 INO80D SCAF1 H2BC15 TOX4 H2BC9 BBX TBRG1 CTCF BRD4 SURF6 H1-0 H1-2 H1-4 H1-5 H2BC5 QSER1 TAF5 SRRM2 DDX24 SNRPD2 HMGN4 RPL4 RPL6 RPL7A H2BC12 | 4.19e-24 | 1294 | 98 | 34 | 30804502 |
| Pubmed | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 DDX24 RPL4 H2BC12 | 3.51e-21 | 277 | 98 | 19 | 30745168 | |
| Pubmed | H2BC11 PSMC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-4 H2BC5 RPL6 H2BC12 | 6.91e-21 | 67 | 98 | 13 | 25253489 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | H2BC11 TRIM25 PSMC1 CHD4 RFC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-4 H1-5 H2BC5 H2BC3 SRRM2 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 1.15e-20 | 626 | 98 | 24 | 33644029 |
| Pubmed | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.24e-20 | 22 | 98 | 10 | 16713563 | |
| Pubmed | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.18e-20 | 23 | 98 | 10 | 16307923 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 | 4.95e-20 | 55 | 98 | 12 | 9439656 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HNRNPDL NOLC1 H1-10 NCOA6 ARID4A SRP72 HMGB2 CHD4 RFC1 H2BC12L H2BC13 H2BC15 TOX4 H2BC9 BBX CTCF TMA7 BRD4 SURF6 H1-2 H2BC5 QSER1 SRRM2 DDX24 SNRPD2 HMGN4 H2BC12 | 7.58e-20 | 954 | 98 | 27 | 36373674 |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 1.83e-19 | 17 | 98 | 9 | 16627869 |
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 4.86e-19 | 11 | 98 | 8 | 26689747 | |
| Pubmed | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.64e-19 | 30 | 98 | 10 | 16319397 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | H2BC11 SP100 PSMC1 GEMIN5 HMGB2 CHD4 H2BC13 H2BC15 H2BC4 H2BC17 TMA7 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 SNRPD2 HMGN4 RPL4 RPL6 RPL7A H2BC12 LRRFIP1 | 8.26e-19 | 847 | 98 | 25 | 35235311 |
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 1.45e-18 | 12 | 98 | 8 | 22650316 | |
| Pubmed | 3.77e-18 | 13 | 98 | 8 | 8858344 | ||
| Pubmed | H1-10 CHD4 RFC1 H2BC13 H2BC15 H2BC17 H2BC21 SURF6 H1-2 H1-3 H1-4 H1-5 H2BC5 DDX24 RPL4 RPL6 RPL7A RBM34 H2BC12 | 8.31e-18 | 419 | 98 | 19 | 15635413 | |
| Pubmed | HNRNPDL NOLC1 H2BC11 H1-10 PSMC1 CHD4 H2BC12L H2BC13 H2BC15 H1-0 H1-2 H1-4 H1-5 H2BC5 H2BC19P SRRM2 SNRPD2 HMGN4 RPL4 RPL6 RPL7A H2BC12 | 8.37e-18 | 652 | 98 | 22 | 31180492 | |
| Pubmed | H1-10 H2BC13 H2BC15 H2BC9 H2BC4 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 | 2.15e-17 | 88 | 98 | 12 | 26318153 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HNRNPDL NOLC1 H1-10 ING2 DHX37 PSMC1 GEMIN5 SRP72 CHD4 RFC1 SCAF1 TOX4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC20P TAF5 SEC63 SRRM2 DDX24 SNRPD2 RPL4 METAP2 RPL6 RPL7A RBM34 | 2.42e-17 | 1318 | 98 | 28 | 30463901 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H1-2 H1-3 H1-4 H2BC5 H2BC3 H1-1 RPL4 RPL6 RPL7A H2BC12 | 4.23e-17 | 212 | 98 | 15 | 23463506 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | HNRNPDL H2BC11 TRIM25 CHD4 RFC1 H2BC13 H2BC15 TOX4 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 RPL4 H2BC12 | 6.34e-17 | 271 | 98 | 16 | 32433965 |
| Pubmed | HNRNPDL H2BC11 H1-10 PSMC1 GEMIN5 SRP72 HMGB2 CHD4 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CTCF H1-2 H1-3 H1-4 H2BC5 H2BC3 H1-1 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 1.01e-16 | 1153 | 98 | 26 | 29845934 | |
| Pubmed | Dynamic changes in H1 subtype composition during epigenetic reprogramming. | 1.35e-16 | 10 | 98 | 7 | 28794128 | |
| Pubmed | Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry. | 4.28e-16 | 6 | 98 | 6 | 15595731 | |
| Pubmed | Hormone-mediated dephosphorylation of specific histone H1 isoforms. | 4.28e-16 | 6 | 98 | 6 | 11479299 | |
| Pubmed | Linker histone transitions during mammalian oogenesis and embryogenesis. | 4.28e-16 | 6 | 98 | 6 | 9499577 | |
| Pubmed | H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain. | 4.28e-16 | 6 | 98 | 6 | 15911621 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HNRNPDL NOLC1 H2BC11 H1-10 SP100 TRIM25 DHX37 PSMC1 SRP72 HMGB2 RFC1 CCN1 SURF6 H1-0 H1-3 H1-5 SEC63 DDX24 SNRPD2 RPL4 METAP2 RPL6 RPL7A RBM34 H2BC12 LRRFIP1 | 7.89e-16 | 1257 | 98 | 26 | 36526897 |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | NOLC1 H1-10 DHX37 KAT6A SRP72 CHD4 MARCKSL1 SCAF1 CTCF SURF6 H1-0 H1-2 H1-4 DDX24 SNRPD2 RPL6 | 1.41e-15 | 330 | 98 | 16 | 33301849 |
| Pubmed | NOLC1 H2BC11 TRIM25 SRP72 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H2BC5 H2BC3 H1-1 H2BC20P H2BC19P SNRPD2 RPL7A H2BC12 | 1.77e-15 | 844 | 98 | 22 | 25963833 | |
| Pubmed | NOLC1 H2BC11 H1-10 DHX37 GEMIN5 SRP72 CHD4 RFC1 H2BC13 CTCF SURF6 H1-3 H1-4 H1-1 SRRM2 DDX24 RPL4 RPL6 RPL7A RBM34 | 1.94e-15 | 653 | 98 | 20 | 22586326 | |
| Pubmed | NOLC1 H2BC11 H1-10 L3MBTL2 DHX37 SRP72 CHD4 RFC1 CTCF SURF6 H1-2 H1-4 DDX24 RPL4 RPL6 RPL7A RBM34 H2BC12 | 2.00e-15 | 483 | 98 | 18 | 36912080 | |
| Pubmed | NOLC1 H1-10 GEMIN5 CHD4 RFC1 BBX CTCF SURF6 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 SRRM2 DDX24 RPL4 RPL6 RPL7A RBM34 | 2.06e-15 | 655 | 98 | 20 | 35819319 | |
| Pubmed | All known human H1 histone genes except the H1(0) gene are clustered on chromosome 6. | 2.99e-15 | 7 | 98 | 6 | 8325638 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.83e-15 | 69 | 98 | 10 | 11689053 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.06e-14 | 73 | 98 | 10 | 14657027 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.06e-14 | 73 | 98 | 10 | 9566873 | |
| Pubmed | NOLC1 H1-10 ARID4A SRP72 HMGB2 RFC1 H2BC4 TMA7 H1-0 H1-2 H1-4 H1-5 SRRM2 RPL4 RPL7A | 1.65e-14 | 317 | 98 | 15 | 30997501 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 H2BC11 H1-10 ING2 DHX37 DAB2 SRP72 CHD4 H2BC4 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 SRRM2 SNRPD2 RPL4 RPL6 RPL7A H2BC12 LRRFIP1 | 1.92e-14 | 949 | 98 | 22 | 36574265 |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | H2BC11 KAT6A H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 2.15e-14 | 203 | 98 | 13 | 16916647 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.84e-14 | 86 | 98 | 10 | 11080476 | |
| Pubmed | Human histone gene organization: nonregular arrangement within a large cluster. | 6.56e-14 | 35 | 98 | 8 | 9119399 | |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 8.60e-14 | 59 | 98 | 9 | 23254330 | |
| Pubmed | HNRNPDL NOLC1 H1-10 TRIM25 CHD4 RFC1 H2BC4 BRD4 SURF6 H1-0 H1-2 H1-3 H1-4 RPL4 RPL7A H2BC12 | 1.25e-13 | 441 | 98 | 16 | 31239290 | |
| Pubmed | The mouse histone H1 genes: gene organization and differential regulation. | 1.60e-13 | 5 | 98 | 5 | 9300059 | |
| Pubmed | 1.60e-13 | 5 | 98 | 5 | 11467742 | ||
| Pubmed | A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences. | 1.60e-13 | 5 | 98 | 5 | 8003976 | |
| Pubmed | Expression of murine H1 histone genes during postnatal development. | 1.60e-13 | 5 | 98 | 5 | 9655912 | |
| Pubmed | 1.96e-13 | 11 | 98 | 6 | 15197225 | ||
| Pubmed | Histone modifications associated with somatic hypermutation. | 1.96e-13 | 11 | 98 | 6 | 16039583 | |
| Pubmed | NOLC1 H1-10 SRP72 CHD4 H2BC21 TMA7 SURF6 H1-0 H1-2 H1-3 H1-4 H2BC5 SRRM2 DDX24 SNRPD2 RPL4 RPL6 RPL7A RBM34 | 1.96e-13 | 731 | 98 | 19 | 29298432 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2BC11 SRP72 CHD4 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-3 H1-4 H2BC5 H2BC3 SRRM2 H2BC12 LRRFIP1 | 4.13e-13 | 477 | 98 | 16 | 31300519 |
| Pubmed | H2BC11 H1-10 RFC1 H2BC12L H2BC15 H2BC9 H1-0 H1-2 H2BC5 RPL4 RPL6 RPL7A | 6.63e-13 | 205 | 98 | 12 | 27976729 | |
| Pubmed | 9.59e-13 | 6 | 98 | 5 | 15562002 | ||
| Pubmed | The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone. | 9.59e-13 | 6 | 98 | 5 | 21425800 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HNRNPDL NOLC1 H1-10 TRIM25 DHX37 PSMC1 GEMIN5 SRP72 CHD4 RFC1 SCAF1 H2BC15 H1-0 H1-2 H2BC5 H2BC20P SEC63 SRRM2 DDX24 SNRPD2 RPL4 RPL6 RPL7A RBM34 | 1.03e-12 | 1425 | 98 | 24 | 30948266 |
| Pubmed | RAP1A DHX37 PSMC1 GEMIN5 SRP72 HMGB2 RFC1 H2BC15 H2BC21 CCN1 SURF6 SEC62 H1-2 H1-4 H1-5 TTC17 SEC63 SRRM2 RPL4 METAP2 RPL6 RPL7A RBM34 | 1.17e-12 | 1297 | 98 | 23 | 33545068 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | HNRNPDL NOLC1 H1-10 SRP72 CHD4 RFC1 H2BC9 H1-0 H1-2 SRRM2 DDX24 SNRPD2 RPL4 RPL6 RPL7A RBM34 H2BC12 | 1.22e-12 | 605 | 98 | 17 | 28977666 |
| Pubmed | HNRNPDL H1-10 H2BC13 CCN1 H1-0 H1-2 H1-4 H1-5 RPL4 RPL6 RPL7A H2BC12 | 1.23e-12 | 216 | 98 | 12 | 37640791 | |
| Pubmed | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 RPL4 RPL6 RPL7A H2BC12 | 1.77e-12 | 438 | 98 | 15 | 21630459 | |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 2.10e-12 | 15 | 98 | 6 | 17690254 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HNRNPDL NOLC1 H1-10 TRIM25 L3MBTL2 DHX37 PSMC1 GEMIN5 CHD4 RFC1 H2BC12L H1-0 H1-2 H1-5 H1-1 SRRM2 DDX24 SNRPD2 RPL4 METAP2 RPL6 RPL7A RBM34 | 2.78e-12 | 1353 | 98 | 23 | 29467282 |
| Pubmed | 3.35e-12 | 16 | 98 | 6 | 33288900 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | HNRNPDL NOLC1 H1-10 DHX37 KAT6A SRP72 CHD4 RFC1 TOX4 SURF6 H1-4 DDX24 SNRPD2 RPL4 RPL6 RPL7A RBM34 LRRFIP1 | 4.17e-12 | 759 | 98 | 18 | 35915203 |
| Pubmed | H2BC11 PSMC1 CHD4 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 RPL4 RPL7A H2BC12 | 4.81e-12 | 878 | 98 | 19 | 37223481 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | H2BC11 H1-10 SRP72 HMGB2 RFC1 H2BC17 CTCF BRD4 H1-2 H2BC5 H2BC3 TAF5 DDX24 H2BC12 | 6.28e-12 | 394 | 98 | 14 | 27248496 |
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | H1-10 SRP72 RFC1 H2BC4 H2BC21 H1-0 H1-2 H1-3 H1-4 H2BC5 H2BC12 | 7.58e-12 | 191 | 98 | 11 | 21907836 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.06e-12 | 256 | 98 | 12 | 35777956 |
| Pubmed | HNRNPDL H2BC11 H1-10 SRP72 HMGB2 CHD4 MARCKSL1 H1-2 ZNF667 H1-4 H2BC3 SNRPD2 RPL4 METAP2 RPL6 RPL7A RBM34 | 1.54e-11 | 711 | 98 | 17 | 33022573 | |
| Pubmed | HNRNPDL NOLC1 NCOA6 TRIM25 PSMC1 SRP72 HMGB2 CHD4 RFC1 INO80D H2BC15 TMA7 BRD4 H1-2 H1-5 QSER1 SRRM2 SNRPD2 HMGN4 METAP2 | 2.94e-11 | 1103 | 98 | 20 | 34189442 | |
| Pubmed | NOLC1 H1-10 SP100 BRPF3 KAT6A CHD4 INO80D SCAF1 TADA1 SLC25A43 CTCF BRD4 SURF6 H1-2 H1-4 H1-5 H2BC3 TAF5 SRRM2 DDX24 | 3.62e-11 | 1116 | 98 | 20 | 31753913 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-2 H1-3 H1-4 H2BC5 H2BC3 SEC63 RPL4 H2BC12 | 3.77e-11 | 451 | 98 | 14 | 36168627 | |
| Pubmed | High-throughput kinase assays with protein substrates using fluorescent polymer superquenching. | 3.99e-11 | 10 | 98 | 5 | 15927069 | |
| Pubmed | H1-10 GOLGA6C DAB2 GOLGA6D PSMC1 GEMIN5 HMGB2 GOLGA6B GOLGA6A HEATR6 AEBP1 | 5.63e-11 | 230 | 98 | 11 | 35449600 | |
| Pubmed | 5.93e-11 | 4 | 98 | 4 | 19072710 | ||
| Pubmed | H1 linker histones are essential for mouse development and affect nucleosome spacing in vivo. | 5.93e-11 | 4 | 98 | 4 | 12808097 | |
| Pubmed | 5.93e-11 | 4 | 98 | 4 | 11746507 | ||
| Pubmed | 5.93e-11 | 4 | 98 | 4 | 10997781 | ||
| Pubmed | Isolation of two murine H1 histone genes and chromosomal mapping of the H1 gene complement. | 5.93e-11 | 4 | 98 | 4 | 8589518 | |
| Pubmed | 5.93e-11 | 4 | 98 | 4 | 11689686 | ||
| Pubmed | 5.93e-11 | 4 | 98 | 4 | 10903929 | ||
| Pubmed | NOLC1 H1-10 NCOA6 L3MBTL2 ARID4A ING2 DHX37 PSMC1 SRP72 HMGB2 RFC1 INO80D TADA1 BBX CTCF SURF6 QSER1 TAF5 SRRM2 DDX24 SNRPD2 RBM34 | 6.05e-11 | 1429 | 98 | 22 | 35140242 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | HNRNPDL H1-10 DHX37 GEMIN5 SRP72 RFC1 H1-0 H1-4 H2BC3 QSER1 DDX24 SNRPD2 RPL4 RPL7A RBM34 H2BC12 | 7.88e-11 | 678 | 98 | 16 | 30209976 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H1-2 H1-3 H1-5 H2BC5 H2BC3 H1-1 RPL7A | 1.21e-10 | 247 | 98 | 11 | 30713523 | |
| Pubmed | HNRNPDL DHX37 RFC1 H2BC12L H2BC13 H2BC4 H1-3 H1-4 H1-5 H2BC5 SRRM2 | 1.37e-10 | 250 | 98 | 11 | 33536335 | |
| Pubmed | H1-10 TRIM25 SRP72 RFC1 H2BC15 H2BC21 H1-0 H1-2 H1-1 SRRM2 SNRPD2 RPL4 RPL6 RPL7A RBM34 | 2.06e-10 | 615 | 98 | 15 | 31048545 | |
| Pubmed | NOLC1 H1-10 NCOA6 SRP72 HMGB2 CHD4 MARCKSL1 RFC1 CCN1 CTCF H1-0 H1-2 H1-3 H1-4 SRRM2 DDX24 SNRPD2 RPL4 RPL6 RPL7A | 2.54e-10 | 1247 | 98 | 20 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HNRNPDL H1-10 RAP1A DHX37 PSMC1 RFC1 H2BC12L H2BC13 H2BC15 H2BC9 H1-2 H1-3 H1-4 H2BC5 H1-1 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 2.92e-10 | 1257 | 98 | 20 | 37317656 |
| Pubmed | Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. | 2.96e-10 | 5 | 98 | 4 | 10893414 | |
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 2.96e-10 | 5 | 98 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 2.96e-10 | 5 | 98 | 4 | 8620898 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | H1-10 TRIM25 DHX37 PSMC1 SRP72 H1-2 H2BC3 H1-1 RPL4 RPL6 RPL7A | 3.36e-10 | 272 | 98 | 11 | 25315684 |
| Pubmed | HNRNPDL H2BC13 H2BC15 H2BC9 H2BC4 H2BC21 H2BC5 H2BC3 DDX24 RPL6 | 3.80e-10 | 206 | 98 | 10 | 22174317 | |
| Pubmed | 4.70e-10 | 15 | 98 | 5 | 28190768 | ||
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 8.85e-10 | 6 | 98 | 4 | 16457587 | |
| Pubmed | 8.85e-10 | 6 | 98 | 4 | 19882353 | ||
| Interaction | H2AC11 interactions | H2BC11 H1-10 CHD4 SCAF1 H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 SURF6 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 DDX24 SNRPD2 HMGN4 RPL7A RBM34 H2BC12 | 1.36e-26 | 248 | 95 | 25 | int:H2AC11 |
| Interaction | H2BC9 interactions | H2BC11 H1-10 HMGB2 CHD4 SCAF1 H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 SPAG17 SNRPD2 HMGN4 RPL4 RPL7A H2BC12 | 9.06e-23 | 446 | 95 | 27 | int:H2BC9 |
| Interaction | H2AC12 interactions | H2BC11 H1-10 CHD4 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC12 | 1.30e-22 | 118 | 95 | 18 | int:H2AC12 |
| Interaction | H2AC14 interactions | H2BC11 H1-10 HMGB2 H2BC15 H2BC9 H2BC17 H2BC21 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC20P HMGN4 H2BC12 | 1.41e-22 | 144 | 95 | 19 | int:H2AC14 |
| Interaction | H3C1 interactions | H2BC11 H1-10 L3MBTL2 DHX37 KAT6A SRP72 HMGB2 CHD4 RFC1 H2BC13 H2BC9 H2BC4 BBX H2BC17 H2BC21 CTCF TMA7 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 TAF5 DDX24 SNRPD2 HMGN4 RPL6 RPL7A RBM34 H2BC12 | 3.60e-22 | 901 | 95 | 34 | int:H3C1 |
| Interaction | H2BC4 interactions | NOLC1 H2BC11 H1-10 SCAF1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 AEBP1 TMA7 BRD4 H1-2 H1-3 H2BC5 H2BC3 SPAG17 SRRM2 SNRPD2 H2BC12 LRRFIP1 | 9.06e-22 | 259 | 95 | 22 | int:H2BC4 |
| Interaction | H2BC12 interactions | NOLC1 H2BC11 H1-10 CHD4 SCAF1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 AEBP1 BRD4 H1-0 H1-2 H1-3 H1-4 H2BC5 H2BC3 SPAG17 SNRPD2 HMGN4 H2BC12 | 5.04e-21 | 322 | 95 | 23 | int:H2BC12 |
| Interaction | H2AC13 interactions | H2BC11 TRIM25 H2BC13 H2BC15 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 RPL7A H2BC12 | 7.20e-21 | 75 | 95 | 15 | int:H2AC13 |
| Interaction | H2AC18 interactions | H2BC11 GEMIN5 HMGB2 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 RPL7A H2BC12 | 9.17e-21 | 148 | 95 | 18 | int:H2AC18 |
| Interaction | H2AC21 interactions | H2BC11 H1-10 CHD4 H2BC15 H2BC9 H2BC17 H2BC21 BRD4 SURF6 H1-0 H1-2 H1-4 H1-5 H2BC5 H2BC3 H1-1 HMGN4 RPL4 RPL7A RBM34 | 6.93e-20 | 234 | 95 | 20 | int:H2AC21 |
| Interaction | H1-10 interactions | H2BC11 H1-10 SP100 KAT6A SRP72 HMGB2 CHD4 H2BC9 H2BC4 H2BC21 CTCF BRD4 H1-0 H1-2 H1-3 H1-5 DDX24 RPL4 METAP2 RPL7A H2BC12 | 1.14e-19 | 280 | 95 | 21 | int:H1-10 |
| Interaction | H3C15 interactions | H2BC11 SP100 HMGB2 CHD4 H2BC13 H2BC9 H2BC4 H2BC21 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 SRRM2 RPL4 H2BC12 | 1.64e-19 | 207 | 95 | 19 | int:H3C15 |
| Interaction | H2BC5 interactions | NOLC1 H2BC11 CHD4 SCAF1 H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TMA7 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 SRRM2 HMGN4 RPL4 H2BC12 | 1.90e-19 | 331 | 95 | 22 | int:H2BC5 |
| Interaction | ADARB1 interactions | HNRNPDL H2BC11 TRIM25 CHD4 RFC1 SCAF1 H2BC13 H2BC15 TOX4 H2BC9 H2BC4 BBX H2BC17 H2BC21 CTCF SURF6 H2BC5 H2BC3 H1-1 DDX24 RPL4 RPL6 RPL7A RBM34 H2BC12 | 2.65e-19 | 489 | 95 | 25 | int:ADARB1 |
| Interaction | H2BC18 interactions | H2BC11 KAT6A H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-4 H1-5 H2BC5 H2BC3 H1-1 HMGN4 RPL7A RBM34 H2BC12 | 3.37e-19 | 180 | 95 | 18 | int:H2BC18 |
| Interaction | H3-4 interactions | H2BC11 H1-10 BRPF3 L3MBTL2 ING2 KAT6A CHD4 H2BC13 H2BC15 TADA1 H2BC9 H2BC4 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 TTC17 H2BC20P TAF5 H2BC12 | 5.27e-19 | 448 | 95 | 24 | int:H3-4 |
| Interaction | H2AC4 interactions | H2BC11 H1-10 SRP72 CHD4 RFC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CTCF BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC20P DDX24 RPL6 H2BC12 | 6.00e-19 | 506 | 95 | 25 | int:H2AC4 |
| Interaction | H2BC21 interactions | H2BC11 H1-10 BRPF3 ARID4A KAT6A CHD4 RFC1 H2BC13 H2BC15 TOX4 H2BC9 H2BC4 H2BC17 H2BC21 TMA7 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 QSER1 SRRM2 HMGN4 H2BC12 | 7.26e-19 | 696 | 95 | 28 | int:H2BC21 |
| Interaction | H2AC6 interactions | H2BC11 H2BC13 H2BC15 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC12 | 7.28e-19 | 100 | 95 | 15 | int:H2AC6 |
| Interaction | HMGA1 interactions | HNRNPDL H2BC11 H1-10 KAT6A HMGB2 CHD4 PPP1R8 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H2BC20P METAP2 H2BC12 | 1.86e-18 | 419 | 95 | 23 | int:HMGA1 |
| Interaction | H1-4 interactions | NOLC1 SP100 DHX37 SRP72 CHD4 RFC1 SCAF1 H2BC9 BBX H2BC21 CTCF BRD4 SURF6 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 SPAG17 DDX24 RPL4 RPL6 RPL7A RBM34 H2BC12 | 1.95e-18 | 656 | 95 | 27 | int:H1-4 |
| Interaction | H2AC7 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC12 | 2.11e-18 | 107 | 95 | 15 | int:H2AC7 |
| Interaction | H2AC25 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC12 | 2.39e-18 | 84 | 95 | 14 | int:H2AC25 |
| Interaction | CDK5R2 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.62e-18 | 23 | 95 | 10 | int:CDK5R2 |
| Interaction | H2BC13 interactions | NOLC1 H2BC11 CHD4 SCAF1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-3 H1-5 H2BC5 H2BC3 SRRM2 HMGN4 RPL7A H2BC12 | 5.52e-18 | 210 | 95 | 18 | int:H2BC13 |
| Interaction | H3-5 interactions | H2BC11 KAT6A HMGB2 CHD4 H2BC13 H2BC9 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 | 5.69e-18 | 114 | 95 | 15 | int:H3-5 |
| Interaction | LARP7 interactions | HNRNPDL NOLC1 H2BC11 H1-10 DHX37 PSMC1 GEMIN5 SRP72 HMGB2 CHD4 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CTCF BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 DDX24 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 2.50e-17 | 1113 | 95 | 32 | int:LARP7 |
| Interaction | HMGN4 interactions | H2BC11 KAT6A H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 BRD4 SURF6 H2BC5 H2BC3 DDX24 HMGN4 H2BC12 | 3.14e-17 | 100 | 95 | 14 | int:HMGN4 |
| Interaction | RIOK1 interactions | HNRNPDL H2BC11 H1-10 TRIM25 PSMC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 SURF6 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 9.32e-17 | 562 | 95 | 24 | int:RIOK1 |
| Interaction | CYLC1 interactions | 1.25e-16 | 20 | 95 | 9 | int:CYLC1 | |
| Interaction | HMGN3 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H2BC5 H2BC3 HMGN4 H2BC12 | 1.58e-16 | 64 | 95 | 12 | int:HMGN3 |
| Interaction | CHD4 interactions | HNRNPDL NOLC1 H1-10 TRIM25 L3MBTL2 KAT6A GEMIN5 CHD4 RFC1 H2BC13 H2BC9 H2BC21 BRD4 H1-0 H1-2 H1-4 H2BC5 H2BC3 H1-1 H2BC20P SRRM2 DDX24 SNRPD2 RPL4 RPL6 RPL7A RBM34 H2BC12 LRRFIP1 | 1.73e-16 | 938 | 95 | 29 | int:CHD4 |
| Interaction | HMGN2 interactions | H2BC11 LRRIQ4 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-2 H1-4 H1-5 H2BC5 H2BC3 H1-1 HMGN4 H2BC12 | 3.36e-16 | 222 | 95 | 17 | int:HMGN2 |
| Interaction | RPS27A interactions | H2BC11 AHI1 TRIM25 CHD4 H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-2 H1-3 H1-4 H2BC5 H2BC3 H1-1 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 4.07e-16 | 536 | 95 | 23 | int:RPS27A |
| Interaction | H3-3A interactions | H2BC11 L3MBTL2 ING2 DHX37 KAT6A HMGB2 CHD4 RFC1 H2BC13 H2BC9 H2BC4 BBX H2BC21 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 QSER1 METAP2 RBM34 H2BC12 LRRFIP1 | 5.76e-16 | 749 | 95 | 26 | int:H3-3A |
| Interaction | TNN interactions | 6.03e-16 | 23 | 95 | 9 | int:TNN | |
| Interaction | SMC5 interactions | HNRNPDL NOLC1 H1-10 NCOA6 ARID4A SRP72 HMGB2 CHD4 RFC1 H2BC12L H2BC13 H2BC15 TOX4 H2BC9 BBX CTCF TMA7 BRD4 SURF6 H1-2 H1-5 H2BC5 H1-1 QSER1 SRRM2 DDX24 SNRPD2 HMGN4 H2BC12 | 9.29e-16 | 1000 | 95 | 29 | int:SMC5 |
| Interaction | RPS19 interactions | H1-10 SP100 TRIM25 KAT6A SRP72 HMGB2 CHD4 H2BC15 TOX4 CTCF BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 SRRM2 DDX24 RPL4 METAP2 RPL6 RPL7A | 1.65e-15 | 639 | 95 | 24 | int:RPS19 |
| Interaction | H1-3 interactions | H1-10 H2BC13 H2BC9 H2BC4 H2BC21 CTCF BRD4 SURF6 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 RPL6 RBM34 H2BC12 | 1.80e-15 | 291 | 95 | 18 | int:H1-3 |
| Interaction | BTF3 interactions | H2BC11 TRIM25 PSMC1 CHD4 RFC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-0 H1-2 H1-4 H1-5 H2BC5 H2BC3 H1-1 SRRM2 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 2.68e-15 | 799 | 95 | 26 | int:BTF3 |
| Interaction | H2BC3 interactions | H2BC11 TRIM25 SRP72 HMGB2 CHD4 RFC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-2 H2BC5 H2BC3 DDX24 HMGN4 RPL6 H2BC12 | 3.27e-15 | 406 | 95 | 20 | int:H2BC3 |
| Interaction | PRKCB interactions | HNRNPDL NOLC1 H2BC11 DAB2 GEMIN5 HMGB2 H2BC13 H2BC15 H2BC21 H1-0 H1-2 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC12 | 3.41e-15 | 255 | 95 | 17 | int:PRKCB |
| Interaction | H2BC17 interactions | H2BC11 BRPF3 KAT6A H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 HMGN4 RPL7A H2BC12 | 3.98e-15 | 140 | 95 | 14 | int:H2BC17 |
| Interaction | H1-2 interactions | H1-10 SP100 TRIM25 KAT6A HMGB2 CHD4 SCAF1 H1-8 H2BC9 H2BC4 H2BC21 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC20P DDX24 RPL6 H2BC12 | 4.13e-15 | 666 | 95 | 24 | int:H1-2 |
| Interaction | RPL31 interactions | NOLC1 H1-10 TRIM25 DHX37 KAT6A SRP72 HMGB2 CHD4 RFC1 SCAF1 BBX CTCF BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 | 6.54e-15 | 680 | 95 | 24 | int:RPL31 |
| Interaction | RPS15 interactions | NOLC1 TRIM25 SRP72 HMGB2 CHD4 CTCF BRD4 SURF6 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 SRRM2 HMGN4 RPL4 METAP2 RPL6 RPL7A | 7.12e-15 | 423 | 95 | 20 | int:RPS15 |
| Interaction | H2AZ1 interactions | H2BC11 KAT6A CHD4 RFC1 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 CTCF BRD4 H1-0 H1-2 H2BC5 H2BC3 H1-1 H2BC20P HMGN4 H2BC12 | 8.64e-15 | 371 | 95 | 19 | int:H2AZ1 |
| Interaction | RPL4 interactions | NOLC1 H1-10 TRIM25 KAT6A GEMIN5 SRP72 HMGB2 CHD4 IQCA1L H2BC9 BBX CTCF BRD4 SURF6 H1-4 H1-5 H2BC5 H1-1 SEC63 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 | 9.03e-15 | 764 | 95 | 25 | int:RPL4 |
| Interaction | KNOP1 interactions | TRIM25 KAT6A CHD4 H2BC13 H2BC15 H2BC4 H2BC17 BRD4 H1-3 H2BC5 H2BC3 H1-1 DDX24 RPL4 RPL7A RBM34 H2BC12 | 9.92e-15 | 272 | 95 | 17 | int:KNOP1 |
| Interaction | DUOX2 interactions | 1.03e-14 | 30 | 95 | 9 | int:DUOX2 | |
| Interaction | RPL22 interactions | TRIM25 KAT6A SRP72 HMGB2 CHD4 H1-8 H2BC15 BBX CTCF SURF6 H1-2 H1-3 H1-4 SRRM2 DDX24 SNRPD2 RPL4 METAP2 RPL6 RPL7A | 1.50e-14 | 440 | 95 | 20 | int:RPL22 |
| Interaction | DDX27 interactions | TRIM25 KAT6A SRP72 CHD4 H2BC4 CTCF BRD4 SURF6 H1-2 H1-4 H1-5 H1-1 DDX24 HMGN4 RPL4 RPL7A RBM34 H2BC12 | 1.52e-14 | 329 | 95 | 18 | int:DDX27 |
| Interaction | RPS16 interactions | H1-10 TRIM25 DHX37 KAT6A PSMC1 GEMIN5 SRP72 HMGB2 CHD4 RFC1 BBX CTCF BRD4 SURF6 H1-3 H1-4 H1-5 H1-1 DDX24 SNRPD2 RPL4 METAP2 RPL6 RPL7A | 2.59e-14 | 724 | 95 | 24 | int:RPS16 |
| Interaction | H2AX interactions | HNRNPDL H2BC11 ARID4A CHD4 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CTCF H1-2 H1-4 H2BC5 H2BC3 H1-1 H2BC20P SRRM2 RPL4 RPL6 RPL7A H2BC12 | 3.86e-14 | 593 | 95 | 22 | int:H2AX |
| Interaction | ICAM1 interactions | H2BC11 H2BC13 H2BC15 HEATR6 H2BC9 H2BC17 H1-2 H1-3 H1-4 H2BC5 H2BC3 H1-1 RPL4 RPL6 RPL7A H2BC12 | 5.08e-14 | 252 | 95 | 16 | int:ICAM1 |
| Interaction | RPL8 interactions | SP100 TRIM25 KAT6A SRP72 HMGB2 CHD4 SCAF1 H1-8 CTCF BRD4 SURF6 H1-2 H1-5 H1-1 DDX24 HMGN4 RPL4 METAP2 RPL6 RPL7A RBM34 | 6.20e-14 | 539 | 95 | 21 | int:RPL8 |
| Interaction | MACROH2A2 interactions | H2BC11 CHD4 RFC1 H2BC15 H2BC4 BBX H2BC21 BRD4 H1-0 DDX24 HMGN4 RPL4 RPL7A RBM34 H2BC12 | 6.37e-14 | 211 | 95 | 15 | int:MACROH2A2 |
| Interaction | NOP2 interactions | NOLC1 KAT6A CHD4 H1-8 H2BC9 BBX H2BC21 BRD4 SURF6 H1-2 H1-4 H1-5 H1-1 DDX24 RPL4 RPL6 RPL7A RBM34 H2BC12 | 6.80e-14 | 416 | 95 | 19 | int:NOP2 |
| Interaction | FAM47B interactions | 6.92e-14 | 13 | 95 | 7 | int:FAM47B | |
| Interaction | RRP8 interactions | DHX37 KAT6A RFC1 SCAF1 H1-8 SURF6 H1-2 H1-3 H1-4 H1-5 H1-1 DDX24 HMGN4 RPL4 RPL7A RBM34 | 7.77e-14 | 259 | 95 | 16 | int:RRP8 |
| Interaction | SURF6 interactions | TRIM25 DHX37 SRP72 RFC1 H1-8 BBX CTCF BRD4 SURF6 H1-3 H1-4 H1-5 H1-1 DDX24 HMGN4 RPL4 RPL6 RPL7A RBM34 | 1.04e-13 | 426 | 95 | 19 | int:SURF6 |
| Interaction | RPS13 interactions | TRIM25 KAT6A PSMC1 SRP72 CHD4 BBX CTCF BRD4 SURF6 H1-3 H1-4 H1-5 H1-1 SRRM2 SNRPD2 RPL4 METAP2 RPL6 RPL7A RBM34 | 1.08e-13 | 489 | 95 | 20 | int:RPS13 |
| Interaction | MEPCE interactions | HNRNPDL H2BC11 SP100 BRPF3 PSMC1 SRP72 H2BC13 H2BC15 TOX4 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-2 H1-3 H1-4 H2BC5 H2BC3 H1-1 SNRPD2 RPL4 RPL6 RPL7A H2BC12 | 1.27e-13 | 859 | 95 | 25 | int:MEPCE |
| Interaction | PPAN-P2RY11 interactions | TRIM25 CHD4 SURF6 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 HMGN4 RPL4 RPL7A RBM34 | 1.54e-13 | 144 | 95 | 13 | int:PPAN-P2RY11 |
| Interaction | RPL6 interactions | HNRNPDL NOLC1 TRIM25 SRP72 HMGB2 CHD4 H1-8 CTCF BRD4 SURF6 H1-2 H1-3 H1-4 H2BC3 H1-1 SRRM2 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 | 1.64e-13 | 637 | 95 | 22 | int:RPL6 |
| Interaction | RPS10 interactions | H1-10 TRIM25 DHX37 SRP72 HMGB2 CHD4 SCAF1 CTCF BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 H1-1 SEC63 DDX24 RPL4 METAP2 RPL6 RPL7A | 1.66e-13 | 567 | 95 | 21 | int:RPS10 |
| Interaction | H2BC26 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-0 H1-4 H2BC5 H2BC3 HMGN4 H2BC12 | 1.69e-13 | 183 | 95 | 14 | int:H2BC26 |
| Interaction | ZNF668 interactions | TRIM25 DHX37 HMGB2 RFC1 CTCF SURF6 H1-3 H1-4 H1-1 DDX24 RPL4 RPL6 VCX RPL7A RBM34 | 1.75e-13 | 226 | 95 | 15 | int:ZNF668 |
| Interaction | IFI16 interactions | H1-10 SP100 DHX37 SRP72 CHD4 RFC1 H2BC13 H2BC21 CTCF BRD4 SURF6 H1-0 H1-2 H1-3 H1-4 H2BC5 SRRM2 DDX24 RPL4 RPL6 RPL7A RBM34 LRRFIP1 | 1.80e-13 | 714 | 95 | 23 | int:IFI16 |
| Interaction | JPH2 interactions | 1.83e-13 | 25 | 95 | 8 | int:JPH2 | |
| Interaction | H1-6 interactions | SCAF1 H1-8 H2BC15 H2BC9 H2BC4 H2BC21 H1-2 H1-3 H1-4 H1-5 H1-1 RPL6 RPL7A RBM34 H2BC12 | 2.12e-13 | 229 | 95 | 15 | int:H1-6 |
| Interaction | NCL interactions | H1-10 TRIM25 SRP72 CHD4 RFC1 H2BC13 H2BC4 H2BC21 CTCF BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 DDX24 SNRPD2 RPL4 METAP2 RPL6 RPL7A H2BC12 | 2.14e-13 | 798 | 95 | 24 | int:NCL |
| Interaction | RPS2 interactions | TRIM25 DHX37 KAT6A PSMC1 SRP72 HMGB2 CHD4 CTCF BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 H1-1 SRRM2 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 | 3.05e-13 | 657 | 95 | 22 | int:RPS2 |
| Interaction | RPLP0 interactions | TRIM25 DHX37 KAT6A SRP72 HMGB2 CHD4 SCAF1 BBX CTCF BRD4 SURF6 H1-2 H1-4 H1-5 H1-1 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 LRRFIP1 | 3.34e-13 | 660 | 95 | 22 | int:RPLP0 |
| Interaction | MACROH2A1 interactions | SP100 VCX2 TRIM25 ARID4A CHD4 H2BC15 H2BC9 H2BC4 H2BC21 CTCF BRD4 H1-0 H1-2 H1-4 H2BC3 H1-1 HMGN4 H2BC12 LRRFIP1 | 3.77e-13 | 458 | 95 | 19 | int:MACROH2A1 |
| Interaction | IGSF8 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H1-2 H1-3 H1-4 H2BC5 H2BC3 H1-1 RPL4 RPL6 RPL7A H2BC12 | 3.95e-13 | 239 | 95 | 15 | int:IGSF8 |
| Interaction | SIRT7 interactions | NOLC1 H2BC11 H1-10 TRIM25 DHX37 GEMIN5 SRP72 CHD4 RFC1 H2BC13 H2BC21 CTCF BRD4 SURF6 H1-3 H1-4 H1-1 SRRM2 DDX24 RPL4 RPL6 RPL7A RBM34 | 4.22e-13 | 744 | 95 | 23 | int:SIRT7 |
| Interaction | PSMD14 interactions | H2BC11 PSMC1 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 DDX24 RPL4 H2BC12 | 4.34e-13 | 527 | 95 | 20 | int:PSMD14 |
| Interaction | RPS24 interactions | HNRNPDL NOLC1 H1-10 TRIM25 DHX37 KAT6A SRP72 CHD4 CTCF BRD4 SURF6 H1-2 H1-4 H1-1 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 | 4.66e-13 | 529 | 95 | 20 | int:RPS24 |
| Interaction | USP36 interactions | NOLC1 H2BC11 H1-10 BRPF3 TRIM25 L3MBTL2 DHX37 SRP72 CHD4 RFC1 CTCF SURF6 H1-2 H1-4 H2BC3 DDX24 RPL4 RPL6 RPL7A RBM34 H2BC12 | 4.77e-13 | 599 | 95 | 21 | int:USP36 |
| Interaction | HEXIM1 interactions | HNRNPDL H2BC11 H1-10 KAT6A PSMC1 SRP72 HMGB2 CHD4 H2BC13 H2BC15 TOX4 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-2 H1-3 H1-4 H2BC5 H2BC3 H1-1 SNRPD2 RPL7A H2BC12 | 4.94e-13 | 913 | 95 | 25 | int:HEXIM1 |
| Interaction | RPL7A interactions | NOLC1 H1-10 TRIM25 KAT6A SRP72 CHD4 H1-8 H2BC13 H2BC9 H2BC17 CTCF BRD4 SURF6 H1-4 H1-1 SRRM2 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 | 5.88e-13 | 679 | 95 | 22 | int:RPL7A |
| Interaction | RPL23A interactions | NOLC1 H1-10 SP100 TRIM25 KAT6A SRP72 HMGB2 CHD4 H2BC9 CTCF BRD4 SURF6 H1-2 H1-4 H1-5 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 | 5.97e-13 | 606 | 95 | 21 | int:RPL23A |
| Interaction | BRIX1 interactions | NOLC1 TRIM25 KAT6A SRP72 CHD4 H1-8 H2BC21 BRD4 H1-2 H1-4 H1-1 DDX24 RPL4 RPL6 RPL7A RBM34 | 7.48e-13 | 300 | 95 | 16 | int:BRIX1 |
| Interaction | RSL1D1 interactions | NOLC1 H1-10 TRIM25 KAT6A CHD4 H1-8 H2BC9 BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 H1-1 DDX24 RPL4 RPL6 RPL7A RBM34 | 8.32e-13 | 479 | 95 | 19 | int:RSL1D1 |
| Interaction | PUM3 interactions | KAT6A CHD4 H1-8 CTCF SURF6 H1-2 H1-3 H1-4 H1-5 H1-1 DDX24 HMGN4 RPL4 RPL7A RBM34 | 9.57e-13 | 254 | 95 | 15 | int:PUM3 |
| Interaction | MCM5 interactions | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H1-2 H1-3 H1-4 H2BC5 H2BC3 H1-1 H2BC20P H2BC19P H2BC12 | 9.79e-13 | 420 | 95 | 18 | int:MCM5 |
| Interaction | FTSJ3 interactions | TRIM25 KAT6A SRP72 CHD4 H1-8 BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 H1-1 DDX24 HMGN4 RPL4 RPL6 RPL7A RBM34 | 1.06e-12 | 422 | 95 | 18 | int:FTSJ3 |
| Interaction | SERBP1 interactions | H2BC11 KAT6A PSMC1 SRP72 HMGB2 CHD4 H2BC12L SCAF1 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 CTCF BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 SEC63 DDX24 RPL4 METAP2 RPL6 RPL7A H2BC12 | 1.35e-12 | 1432 | 95 | 30 | int:SERBP1 |
| Interaction | H2BC14 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 TMA7 H2BC5 H2BC3 HMGN4 H2BC12 | 1.41e-12 | 100 | 95 | 11 | int:H2BC14 |
| Interaction | RRP12 interactions | H1-10 KAT6A SRP72 CHD4 H2BC4 BRD4 SURF6 H1-2 H1-4 H1-5 H2BC3 H1-1 DDX24 RPL4 RPL6 H2BC12 | 2.00e-12 | 320 | 95 | 16 | int:RRP12 |
| Interaction | RPL36 interactions | HNRNPDL H1-10 TRIM25 KAT6A SRP72 HMGB2 SCAF1 H2BC4 CTCF BRD4 SURF6 H1-3 H1-4 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 | 2.03e-12 | 504 | 95 | 19 | int:RPL36 |
| Interaction | RBM19 interactions | TRIM25 DHX37 CHD4 CTCF SURF6 H1-2 H1-3 H1-4 H1-5 H1-1 DDX24 HMGN4 RPL4 RPL7A | 2.25e-12 | 221 | 95 | 14 | int:RBM19 |
| Interaction | RPS3A interactions | TRIM25 DHX37 KAT6A SRP72 HMGB2 CHD4 CTCF BRD4 SURF6 H1-2 H1-4 H1-5 H1-1 SRRM2 DDX24 RPL4 METAP2 RPL6 RPL7A RBM34 LRRFIP1 | 2.63e-12 | 655 | 95 | 21 | int:RPS3A |
| Interaction | GNL2 interactions | BRPF3 TRIM25 SRP72 CHD4 RFC1 POLR3G BBX BRD4 SURF6 H1-3 H1-4 H1-1 HMGN4 RPL4 METAP2 RPL7A RBM34 | 2.91e-12 | 386 | 95 | 17 | int:GNL2 |
| Interaction | POP1 interactions | SP100 KAT6A SRP72 TOX4 BRD4 SURF6 H1-0 H1-2 H1-3 H1-4 H2BC3 H1-1 RPL4 RPL7A RBM34 | 3.34e-12 | 277 | 95 | 15 | int:POP1 |
| Interaction | H2BC15 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TMA7 H2BC5 H2BC3 HMGN4 H2BC12 | 3.66e-12 | 144 | 95 | 12 | int:H2BC15 |
| Interaction | H2BC11 interactions | H2BC11 H1-10 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H2BC5 H2BC3 HMGN4 H2BC12 | 4.17e-12 | 186 | 95 | 13 | int:H2BC11 |
| Interaction | WDR5 interactions | HNRNPDL H2BC11 H1-10 NCOA6 L3MBTL2 ING2 SRRM4 KAT6A SRP72 HMGB2 CHD4 MARCKSL1 H2BC21 CTCF BRD4 H1-2 ZNF667 H1-4 H2BC3 H1-1 SNRPD2 RPL4 METAP2 RPL6 RPL7A RBM34 | 4.43e-12 | 1101 | 95 | 26 | int:WDR5 |
| Interaction | NPM1 interactions | H1-10 DHX37 KAT6A GEMIN5 SRP72 CHD4 RFC1 SCAF1 H2BC4 H2BC21 CTCF BRD4 SURF6 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 H2BC20P DDX24 SNRPD2 HMGN4 RPL4 RPL6 RPL7A RBM34 | 4.84e-12 | 1201 | 95 | 27 | int:NPM1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 HMGN4 H2BC12 | 4.04e-15 | 378 | 98 | 15 | chr6p22 |
| Cytoband | 6p21.3 | 3.76e-09 | 250 | 98 | 9 | 6p21.3 | |
| Cytoband | 6p22.1 | 6.56e-07 | 142 | 98 | 6 | 6p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q24 | 1.41e-04 | 122 | 98 | 4 | chr15q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp22 | 2.07e-04 | 250 | 98 | 5 | chrXp22 | |
| Cytoband | 1q21.2 | 4.85e-04 | 71 | 98 | 3 | 1q21.2 | |
| Cytoband | Xp22 | 1.31e-03 | 25 | 98 | 2 | Xp22 | |
| Cytoband | 3q26.2 | 1.53e-03 | 27 | 98 | 2 | 3q26.2 | |
| Cytoband | 15q24.2 | 2.15e-03 | 32 | 98 | 2 | 15q24.2 | |
| Cytoband | 15q24.1 | 2.42e-03 | 34 | 98 | 2 | 15q24.1 | |
| GeneFamily | Histones | H2BC11 H1-10 H2BC12L H1-8 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC20P H2BC19P H2BC12 | 1.95e-30 | 116 | 68 | 21 | 864 |
| GeneFamily | Variable charge X/Y family | 2.73e-09 | 6 | 68 | 4 | 368 | |
| GeneFamily | PHD finger proteins | 2.22e-05 | 90 | 68 | 5 | 88 | |
| GeneFamily | Canonical high mobility group | 7.50e-04 | 11 | 68 | 2 | 511 | |
| GeneFamily | L ribosomal proteins | 9.31e-04 | 51 | 68 | 3 | 729 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 3.43e-09 | 198 | 97 | 10 | MM17083 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | H2BC11 H1-10 MARCKSL1 H2BC13 H2BC15 H2BC4 H2BC21 H2BC5 TAF5 H2BC12 | 3.77e-09 | 200 | 97 | 10 | M9952 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | H2BC11 SP100 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 TBRG1 H1-2 H1-4 H2BC5 H2BC3 SNRPD2 H2BC12 | 1.46e-07 | 768 | 97 | 15 | M6444 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | NOLC1 H2BC11 ING2 H2BC13 H2BC9 H2BC4 H2BC17 H1-3 H1-5 H2BC5 H2BC3 H1-1 RPL4 H2BC12 | 3.79e-07 | 714 | 97 | 14 | M1744 |
| Coexpression | FISCHER_DREAM_TARGETS | HNRNPDL NOLC1 AHI1 L3MBTL2 HMGB2 RFC1 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 CTCF H1-2 H1-3 H1-5 TAF5 | 5.15e-07 | 969 | 97 | 16 | M149 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | NOLC1 SP100 SRP72 HMGB2 POLR3G PPP1R8 CTCF TAF5 SNRPD2 HMGN4 RPL4 METAP2 RPL6 RBM34 | 8.09e-07 | 761 | 97 | 14 | M11961 |
| Coexpression | HASLINGER_B_CLL_WITH_6Q21_DELETION | 1.22e-06 | 22 | 97 | 4 | M7362 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.56e-06 | 96 | 97 | 6 | M1683 | |
| Coexpression | ZHENG_CORD_BLOOD_C5_SIMILAR_TO_HSC_C6_PUTATIVE_ALTERED_METABOLIC_STATE | 1.65e-06 | 97 | 97 | 6 | M39214 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 3.64e-06 | 111 | 97 | 6 | MM705 | |
| Coexpression | MENON_FETAL_KIDNEY_1_EMBRYONIC_RED_BLOOD_CELLS | 7.57e-06 | 126 | 97 | 6 | M39251 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | BRPF3 ARID4A KAT6A RFC1 INO80D H2BC4 BBX TBRG1 H1-2 DDX24 METAP2 LRRFIP1 | 8.04e-06 | 680 | 97 | 12 | M41089 |
| Coexpression | DANG_BOUND_BY_MYC | HNRNPDL H2BC11 TRIM25 ARID4A GAS8 POLR3G H2BC12L H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 SURF6 SEC62 SRRM2 | 8.05e-06 | 1061 | 97 | 15 | M15774 |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 9.44e-06 | 199 | 97 | 7 | M9954 | |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | 9.75e-06 | 200 | 97 | 7 | M107 | |
| Coexpression | GSE22886_CTRL_VS_LPS_24H_DC_DN | 9.75e-06 | 200 | 97 | 7 | M4520 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DN | 9.75e-06 | 200 | 97 | 7 | M4949 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN | 9.75e-06 | 200 | 97 | 7 | M4968 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST | 1.28e-05 | 81 | 97 | 5 | M45667 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.30e-05 | 384 | 97 | 9 | M1865 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NOLC1 NCOA6 SP100 RAP1A SRP72 HMGB2 CNKSR2 RFC1 POLR3G CTCF H1-4 TAF5 HMGN4 RPL4 METAP2 RPL6 LRRFIP1 | 1.31e-05 | 1394 | 97 | 17 | M9585 |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.87e-05 | 402 | 97 | 9 | MM1248 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS | 2.03e-05 | 310 | 97 | 8 | M41748 | |
| Coexpression | JONES_OVARY_GRANULOSA | 2.93e-05 | 96 | 97 | 5 | M48347 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN | GOLGA6C GOLGA6D PSMC1 GOLGA6B GOLGA6A TMA7 SEC62 SEC63 SNRPD2 RPL4 | 3.74e-05 | 550 | 97 | 10 | MM1004 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP | 3.99e-05 | 443 | 97 | 9 | M40870 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | H2BC11 AHI1 DAB2 H2BC13 H2BC15 H2BC9 H2BC4 CTCF H1-5 H2BC3 H1-1 | 5.23e-05 | 694 | 97 | 11 | M45767 |
| Coexpression | ACEVEDO_LIVER_CANCER_UP | NCOA6 SRP72 HMGB2 H2BC12L TOX4 BBX H2BC21 CTCF H1-2 HMGN4 RPL7A RBM34 H2BC12 | 6.05e-05 | 972 | 97 | 13 | M15709 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 6.49e-05 | 269 | 97 | 7 | M41203 | |
| Coexpression | KENNEDY_PBMC_DRYVAX_AGE_18_50YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_UP | 7.19e-05 | 22 | 97 | 3 | M41188 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP | 8.85e-05 | 195 | 97 | 6 | M3184 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DN | 9.36e-05 | 197 | 97 | 6 | M4946 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP | 9.62e-05 | 198 | 97 | 6 | M4291 | |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN | 9.89e-05 | 199 | 97 | 6 | M7667 | |
| Coexpression | GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP | 9.89e-05 | 199 | 97 | 6 | M3182 | |
| Coexpression | GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN | 1.02e-04 | 200 | 97 | 6 | M5139 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN | 1.02e-04 | 200 | 97 | 6 | M7829 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP | 1.02e-04 | 200 | 97 | 6 | M5416 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_DN | 1.10e-04 | 203 | 97 | 6 | M15912 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 1.10e-04 | 203 | 97 | 6 | MM3795 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 1.20e-04 | 206 | 97 | 6 | M39254 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | HNRNPDL H1-10 RAP1A KAT6A CHD4 TMA7 SEC62 DDX24 HMGN4 RPL4 RPL6 LRRFIP1 | 1.37e-04 | 911 | 97 | 12 | M40038 |
| Coexpression | HAY_BONE_MARROW_PRO_B | 1.39e-04 | 304 | 97 | 7 | M39208 | |
| Coexpression | HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP | 1.50e-04 | 28 | 97 | 3 | M2553 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE | 1.54e-04 | 136 | 97 | 5 | M40899 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SURVIVAL_UP | 1.58e-04 | 73 | 97 | 4 | M6939 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_INTERMEDIATE_MONOCYTE_AGEING | 1.67e-04 | 419 | 97 | 8 | MM3768 | |
| Coexpression | JIANG_MELANOMA_TRM8_CD4 | 1.87e-04 | 426 | 97 | 8 | M48972 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CLASSICAL_MONOCYTE_AGEING | 2.36e-04 | 441 | 97 | 8 | MM3765 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | HNRNPDL PSMC1 HMGB2 CHD4 CTCF SEC62 H1-2 SRRM2 SNRPD2 RPL4 METAP2 RPL6 RPL7A | 3.02e-04 | 1144 | 97 | 13 | MM3843 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 3.46e-04 | 467 | 97 | 8 | M1347 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 3.55e-04 | 163 | 97 | 5 | M8235 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HNRNPDL RAP1A ARID4A KAT6A INO80D BBX TBRG1 CTCF TMA7 DDX24 HMGN4 RPL4 RPL6 RPL7A LRRFIP1 | 3.75e-04 | 1492 | 97 | 15 | M40023 |
| Coexpression | GAUTAM_EYE_CORNEA_FIBROBLASTS | 3.76e-04 | 165 | 97 | 5 | M43617 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 4.28e-04 | 366 | 97 | 7 | M2461 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 4.39e-04 | 484 | 97 | 8 | MM999 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP | 4.42e-04 | 368 | 97 | 7 | M16431 | |
| Coexpression | DORN_ADENOVIRUS_INFECTION_24HR_DN | 5.08e-04 | 42 | 97 | 3 | M8825 | |
| Coexpression | BARRIER_COLON_CANCER_RECURRENCE_UP | 5.08e-04 | 42 | 97 | 3 | M9728 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 5.18e-04 | 378 | 97 | 7 | MM1077 | |
| Coexpression | FAN_OVARY_CL10_PUTATIVE_EARLY_ATRESIA_GRANULOSA_CELL | 5.51e-04 | 274 | 97 | 6 | M41712 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 5.67e-04 | 102 | 97 | 4 | M10290 | |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | H2BC11 TRIM25 ARID4A POLR3G H2BC12L H2BC15 H2BC9 H2BC4 H2BC21 SEC62 | 5.98e-04 | 775 | 97 | 10 | M17753 |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN | 6.33e-04 | 185 | 97 | 5 | M9004 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | NOLC1 H2BC11 H1-10 L3MBTL2 DAB2 GEMIN5 HMGB2 POLR3G H2BC13 H2BC15 H2BC17 TMA7 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 SNRPD2 HMGN4 RPL7A H2BC12 | 6.79e-08 | 1429 | 96 | 23 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#1 | NOLC1 SFRP1 H2BC15 H2BC17 TMA7 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 | 1.13e-07 | 300 | 96 | 11 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K1 |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 3.11e-07 | 32 | 96 | 5 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.78e-07 | 275 | 96 | 10 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 7.57e-07 | 70 | 96 | 6 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 | NOLC1 H1-10 L3MBTL2 DAB2 GEMIN5 HMGB2 POLR3G H2BC13 H2BC15 TMA7 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 SNRPD2 HMGN4 RPL7A | 1.09e-06 | 1175 | 96 | 19 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K4 | NOLC1 H2BC11 H1-10 L3MBTL2 GEMIN5 CHD4 MARCKSL1 H2BC13 H2BC15 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC12 | 2.54e-06 | 1125 | 96 | 18 | facebase_RNAseq_e9.5_MaxArch_2500_K4 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 3.07e-06 | 50 | 96 | 5 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.54e-06 | 268 | 96 | 9 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | NOLC1 H2BC11 SFRP1 HMGB2 RFC1 POLR3G H2BC13 H2BC15 H2BC17 TMA7 SURF6 H1-4 H2BC5 H2BC3 H1-1 HMGN4 RPL6 H2BC12 | 6.38e-06 | 1202 | 96 | 18 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500 | NOLC1 H2BC11 GEMIN5 POLR3G H2BC13 H2BC15 H2BC17 TMA7 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 HMGN4 RPL6 H2BC12 | 8.37e-06 | 1226 | 96 | 18 | facebase_RNAseq_e9.5_FaceMes_2500 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | 8.91e-06 | 162 | 96 | 7 | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#3 | 9.63e-06 | 108 | 96 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | NOLC1 AHI1 SFRP1 GEMIN5 HMGB2 RFC1 TULP1 POLR3G BBX CTCF TMA7 BRD4 SURF6 H1-4 H1-1 SRRM2 HMGN4 RPL7A LRRFIP1 | 1.03e-05 | 1371 | 96 | 19 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 1.07e-05 | 110 | 96 | 6 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 1.07e-05 | 110 | 96 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | 1.87e-05 | 72 | 96 | 5 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | 2.22e-05 | 125 | 96 | 6 | facebase_RNAseq_e9.5_MandArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 3.13e-05 | 80 | 96 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 3.15e-05 | 133 | 96 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K4 | NOLC1 GEMIN5 POLR3G H2BC13 H2BC15 H2BC17 TMA7 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 HMGN4 RPL6 | 3.37e-05 | 983 | 96 | 15 | facebase_RNAseq_e9.5_FaceMes_2500_K4 |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#5 | SP100 RAP1A ARID4A PSMC1 SRP72 RFC1 SURF6 SEC62 TAF5 SNRPD2 RPL4 RPL6 RPL7A | 3.68e-05 | 759 | 96 | 13 | JC_iEC_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.72e-05 | 137 | 96 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500 | NOLC1 H2BC11 H1-10 L3MBTL2 GEMIN5 CHD4 MARCKSL1 H2BC13 H2BC15 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC3 H1-1 H2BC12 | 3.74e-05 | 1371 | 96 | 18 | facebase_RNAseq_e9.5_MaxArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | 6.52e-05 | 482 | 96 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.01e-04 | 164 | 96 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K2 | 1.04e-04 | 54 | 96 | 4 | facebase_RNAseq_e9.5_FaceMes_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | BRPF3 AHI1 ARID4A SRRM4 KAT6A TOX4 H2BC9 H2BC21 CCN1 H1-2 H1-3 H1-4 H2BC3 SRRM3 | 1.26e-04 | 979 | 96 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.29e-04 | 57 | 96 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | 1.38e-04 | 58 | 96 | 4 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.41e-04 | 123 | 96 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | NOLC1 H1-10 HMGB2 RFC1 POLR3G SCAF1 H2BC13 H2BC15 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 | 2.74e-04 | 1187 | 96 | 15 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 3.02e-04 | 71 | 96 | 4 | GSM605778_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#4 | NOLC1 L3MBTL2 ING2 GEMIN5 RFC1 POLR3G SURF6 SNRPD2 RPL6 RPL7A | 3.23e-04 | 587 | 96 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K4 |
| CoexpressionAtlas | bone marrow | 3.63e-04 | 292 | 96 | 7 | bone marrow | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | 3.84e-04 | 491 | 96 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 4.40e-04 | 397 | 96 | 8 | GSM791143_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th.TCRbko, TCRd+ Vg1.1+, Thymus, avg-3 | 4.55e-04 | 79 | 96 | 4 | GSM605784_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.59e-04 | 217 | 96 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NOLC1 NCOA6 RAP1A AHI1 SFRP1 L3MBTL2 ARID4A HMGB2 CHD4 RFC1 BRD4 H1-1 QSER1 TAF5 SEC63 | 5.01e-04 | 1257 | 96 | 15 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | NOLC1 H1-10 SFRP1 L3MBTL2 DHX37 SRRM4 POLR3G H1-4 H1-5 H2BC3 SRRM3 SNRPD2 RPL6 | 5.12e-04 | 991 | 96 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 | H2BC11 H1-10 CNKSR2 H2BC13 H2BC15 H2BC17 TMA7 H1-2 H1-4 H2BC5 H2BC3 H1-1 SNRPD2 HMGN4 H2BC12 | 5.40e-04 | 1266 | 96 | 15 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 6.18e-04 | 418 | 96 | 8 | GSM538350_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 7.12e-04 | 327 | 96 | 7 | GSM605778_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | 7.38e-04 | 157 | 96 | 5 | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | |
| CoexpressionAtlas | B cells, B.Pl.AA4+220-.BM, CD138+ AA4.1+ CD43- CD45R-, Bone marrow, avg-3 | 8.79e-04 | 339 | 96 | 7 | GSM777027_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | 9.69e-04 | 43 | 96 | 3 | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | NOLC1 SFRP1 GEMIN5 HMGB2 RFC1 POLR3G H2BC13 H2BC15 TMA7 SURF6 H2BC5 HMGN4 RPL6 RPL7A H2BC12 | 1.02e-03 | 1347 | 96 | 15 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | 1.04e-03 | 349 | 96 | 7 | GSM476675_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | NOLC1 SFRP1 HMGB2 RFC1 POLR3G H2BC15 TMA7 SURF6 H1-4 H2BC3 H1-1 HMGN4 RPL6 | 1.13e-03 | 1080 | 96 | 13 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th.TCRbko, TCRd+ Vg1.1+, Thymus, avg-3 | 1.28e-03 | 362 | 96 | 7 | GSM605784_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.46e-03 | 593 | 96 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | ECTO amniotic fluid MSC_vs_ECTO blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.46e-03 | 183 | 96 | 5 | PCBC_ratio_ECTO amniotic fluid MSC_vs_ECTO blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | 1.52e-03 | 373 | 96 | 7 | GSM605781_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | NOLC1 H1-10 DHX37 GEMIN5 POLR3G PPP1R8 SCAF1 SURF6 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 | 1.54e-03 | 1259 | 96 | 14 | facebase_RNAseq_e9.5_MandArch_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 1.55e-03 | 374 | 96 | 7 | GSM538389_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | 1.56e-03 | 483 | 96 | 8 | Facebase_RNAseq_e9.5_Maxillary Arch_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3 | 1.60e-03 | 376 | 96 | 7 | GSM791154_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 1.60e-03 | 376 | 96 | 7 | GSM538418_500 | |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | SRRM4 GAS8 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CCN1 H2BC5 H2BC12 | 1.66e-03 | 727 | 96 | 10 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | 1.69e-03 | 52 | 96 | 3 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | 1.69e-03 | 380 | 96 | 7 | GSM538207_500 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | H2BC11 HMGB2 RFC1 H2BC15 H1-3 H1-4 H1-5 H2BC3 H1-1 SRRM2 SNRPD2 H2BC12 | 1.04e-14 | 186 | 98 | 12 | 15ab6666748a641226e42e6ca6eeaf186a501c95 |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | H2BC11 HMGB2 RFC1 H2BC15 H1-3 H1-4 H1-5 H2BC3 H1-1 SRRM2 SNRPD2 H2BC12 | 1.04e-14 | 186 | 98 | 12 | 4ed1b97e2552f3c4134f25665d7513498ffac16c |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 1.77e-11 | 194 | 98 | 10 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 5.29e-10 | 196 | 98 | 9 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.33e-10 | 200 | 98 | 9 | b340b6acf675c75adffb98e560080f966571f594 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.61e-09 | 167 | 98 | 8 | afb6d0993f3fd44a295874673055189d514f7b11 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.79e-09 | 181 | 98 | 8 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-09 | 181 | 98 | 8 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-09 | 181 | 98 | 8 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 6.79e-09 | 181 | 98 | 8 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.52e-09 | 189 | 98 | 8 | c502f0cf16fac9f09891d288dcf0149b9eee9d10 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 192 | 98 | 8 | 5155f746ad57122ef735da776c96721005b8dadc | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 1.12e-08 | 193 | 98 | 8 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-08 | 196 | 98 | 8 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.32e-08 | 197 | 98 | 8 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | BL-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.37e-08 | 198 | 98 | 8 | 1c0227e58a64c0bf509bfb9578fb91277316b120 | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.37e-08 | 198 | 98 | 8 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-08 | 198 | 98 | 8 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.37e-08 | 198 | 98 | 8 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-08 | 198 | 98 | 8 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.42e-08 | 199 | 98 | 8 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | H1299-uninfected|H1299 / Cell line, Condition and Strain | 1.42e-08 | 199 | 98 | 8 | 4594eb3e6d29285155df8dfd322ccf532d7e94b8 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.48e-08 | 200 | 98 | 8 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG|World / Primary Cells by Cluster | 1.48e-08 | 200 | 98 | 8 | 7596143925cd403ec7baceef87d19d570e48586a | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.48e-08 | 200 | 98 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 1.48e-08 | 200 | 98 | 8 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | 5'-GW_trimst-1|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 200 | 98 | 8 | a4c6d0cccba7aee35eaedf29faff32b9494b6582 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-07 | 171 | 98 | 7 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 174 | 98 | 7 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 174 | 98 | 7 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-07 | 180 | 98 | 7 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-07 | 180 | 98 | 7 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|World / disease group, cell group and cell class (v2) | 2.14e-07 | 190 | 98 | 7 | 7aaf82f0c235363afb95cf1fa51c2a5b070b1af8 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-07 | 194 | 98 | 7 | ded64ddab86de17fcf8b70d31bc26796eb71d60f | |
| ToppCell | Control-PLT_1|Control / Disease Group and Platelet Clusters | 2.56e-07 | 195 | 98 | 7 | 20ee45983a5675d9fa072d02dd45c6ce8662d7d7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.56e-07 | 195 | 98 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | COVID-19_Severe|World / disease group, cell group and cell class | 2.65e-07 | 196 | 98 | 7 | 3bedf60f662b373ad9d0f07d4da9f11864af3a74 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-07 | 197 | 98 | 7 | 853162b116f808dccc295cbab83b0ba98d23b006 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.74e-07 | 197 | 98 | 7 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.74e-07 | 197 | 98 | 7 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | 3'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-07 | 197 | 98 | 7 | 03646005921bc330b7a9f66889ef1a7b9a3d530e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.74e-07 | 197 | 98 | 7 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.74e-07 | 197 | 98 | 7 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | lymphoid-T_cell-CD4+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 2.83e-07 | 198 | 98 | 7 | d5f0b4cb92de19e1ddd03d13b4f9a8a560ef4f36 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-07 | 198 | 98 | 7 | ea6621a148a96c8ffa1a93a35c9e288545d2637a | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 2.93e-07 | 199 | 98 | 7 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.93e-07 | 199 | 98 | 7 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.93e-07 | 199 | 98 | 7 | 4366ead68736ae3a2cefac71fd349d526cccb611 | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 3.03e-07 | 200 | 98 | 7 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.03e-07 | 200 | 98 | 7 | 7b7a5800798a3e7eba164fbc28312dd09c57a2c3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.03e-07 | 200 | 98 | 7 | fc73565f973c70915e7415f30d7295a63e33d712 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.03e-07 | 200 | 98 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 3.03e-07 | 200 | 98 | 7 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | megakaryocytic-Megakaryocyte|megakaryocytic / Lineage and Cell class | 3.03e-07 | 200 | 98 | 7 | 806e745ac1556b8158719f14a757df6e6d7ac77f | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.03e-07 | 200 | 98 | 7 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 3.03e-07 | 200 | 98 | 7 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia|World / Primary Cells by Cluster | 3.03e-07 | 200 | 98 | 7 | ecbbad00e16041a9e1cd88d8bd7279a1b52c0aa4 | |
| ToppCell | moderate-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.39e-07 | 130 | 98 | 6 | a04057bd4f256d09eca06b8c1e8b41425bb4ef3f | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 165 | 98 | 6 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 165 | 98 | 6 | 4297588f809e8a8275ab1a6ed99daac7ad93bd61 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-06 | 167 | 98 | 6 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.18e-06 | 171 | 98 | 6 | 846a9acfff0bf0a9baf65dc07b7d7a9217ed6598 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 173 | 98 | 6 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 173 | 98 | 6 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-06 | 174 | 98 | 6 | 723848d2f8ae9cf4f15d4b4a130f9a64dab443c7 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|tumor_Lung / Location, Cell class and cell subclass | 2.74e-06 | 178 | 98 | 6 | c57f92e57548638f1627dc7d313137f406dbecff | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 179 | 98 | 6 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 179 | 98 | 6 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-06 | 180 | 98 | 6 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-06 | 181 | 98 | 6 | f1d88b83a13acd1c8e6b9ff8bd0acaff3650ceef | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-06 | 181 | 98 | 6 | 70cd612706640d8ebf0e047582b1daa2c1121526 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.12e-06 | 102 | 98 | 5 | f1d960a227a741e568831974c2a7f4b3e6bc9957 | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 3.12e-06 | 182 | 98 | 6 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.43e-06 | 185 | 98 | 6 | 698ff44fd2d9b3ad5cea45f4cff9bfc64c559b62 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.54e-06 | 186 | 98 | 6 | 981116561986f94e9cc3ee64fb37dab9a31d427a | |
| ToppCell | B_cell_maturation-immature_B_cell|B_cell_maturation / Lineage and Cell class | 3.65e-06 | 187 | 98 | 6 | 9afbb21654c8eb6f9c6a7cbd0664d890282ddceb | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 3.76e-06 | 188 | 98 | 6 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 190 | 98 | 6 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 190 | 98 | 6 | e38dc41f2e79e3bd51326581c6ebe51927edb549 | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 4.12e-06 | 191 | 98 | 6 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | 3'_v3-bone_marrow|World / Manually curated celltypes from each tissue | 4.12e-06 | 191 | 98 | 6 | 7b759831f1b1c8575c31f67d0d9eb11c6a833cf3 | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 4.12e-06 | 191 | 98 | 6 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 4.37e-06 | 193 | 98 | 6 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|World / disease group, cell group and cell class | 4.37e-06 | 193 | 98 | 6 | ddc1db516568e03be8e82b2ca770c67756418185 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.37e-06 | 193 | 98 | 6 | 9b97a7e9b5c1cc5db353070af0b9c5059714724b | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Pro-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.50e-06 | 194 | 98 | 6 | 58d7c56d2b9c893b62da2334428d677e3451fe07 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 4.50e-06 | 194 | 98 | 6 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 195 | 98 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 4.64e-06 | 195 | 98 | 6 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | normal_Pleural_Fluid|World / Location, Cell class and cell subclass | 4.78e-06 | 196 | 98 | 6 | 7029c9f4a826f6cfdcb5f7a472fba94e8945a771 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 4.78e-06 | 196 | 98 | 6 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | control-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.78e-06 | 196 | 98 | 6 | 25994ca143701c72d2f84a3b6d348fcfa1d26a54 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 4.78e-06 | 196 | 98 | 6 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | 5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.78e-06 | 196 | 98 | 6 | a579211ef14f348d0c5a290553150222dfbf1515 | |
| ToppCell | COVID-19_Severe|World / Disease group, lineage and cell class | 4.92e-06 | 197 | 98 | 6 | f0824f98269bdcd8463873beaf222df8f0caa468 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.92e-06 | 197 | 98 | 6 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | PBMC-Severe|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.92e-06 | 197 | 98 | 6 | af10b5e6e959e2ced01ad066f906941bc4194cc3 | |
| ToppCell | Severe-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.92e-06 | 197 | 98 | 6 | 0905417e3fa7424575bc48e8054256d5799306d7 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-06 | 197 | 98 | 6 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-06 | 197 | 98 | 6 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| Computational | Genes in the cancer module 127. | 1.75e-14 | 26 | 65 | 9 | MODULE_127 | |
| Computational | Genes in the cancer module 189. | 5.23e-13 | 23 | 65 | 8 | MODULE_189 | |
| Computational | Genes in the cancer module 203. | 2.32e-12 | 16 | 65 | 7 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 3.93e-12 | 17 | 65 | 7 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 6.41e-12 | 18 | 65 | 7 | MODULE_552 | |
| Computational | Genes in the cancer module 222. | 3.37e-11 | 22 | 65 | 7 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 3.37e-11 | 22 | 65 | 7 | MODULE_168 | |
| Computational | Genes in the cancer module 89. | 1.12e-10 | 14 | 65 | 6 | MODULE_89 | |
| Computational | Chromatin. | 2.27e-10 | 28 | 65 | 7 | MODULE_421 | |
| Computational | Genes in the cancer module 534. | 6.77e-10 | 18 | 65 | 6 | MODULE_534 | |
| Computational | Genes in the cancer module 98. | H1-10 HMGB2 CHD4 RFC1 PPP1R8 TOX4 H2BC21 CTCF H1-2 TAF5 HMGN4 H2BC12 | 3.36e-06 | 393 | 65 | 12 | MODULE_98 |
| Computational | Neighborhood of NPM1 | 7.08e-05 | 72 | 65 | 5 | GNF2_NPM1 | |
| Computational | Neighborhood of DAP3 | 7.87e-05 | 119 | 65 | 6 | GNF2_DAP3 | |
| Computational | rRNA processing and DNA repair. | 1.61e-04 | 18 | 65 | 3 | MODULE_392 | |
| Computational | Neighborhood of ST13 | 5.89e-04 | 64 | 65 | 4 | GNF2_ST13 | |
| Computational | Genes in the cancer module 197. | 6.18e-04 | 174 | 65 | 6 | MODULE_197 | |
| Computational | Genes in the cancer module 123. | 6.95e-04 | 247 | 65 | 7 | MODULE_123 | |
| Computational | Neighborhood of ANP32B | 1.21e-03 | 198 | 65 | 6 | MORF_ANP32B | |
| Computational | Genes in the cancer module 17. | 1.55e-03 | 366 | 65 | 8 | MODULE_17 | |
| Computational | Neighborhood of EIF4E | 1.71e-03 | 85 | 65 | 4 | MORF_EIF4E | |
| Computational | Genes in the cancer module 198. | 2.27e-03 | 303 | 65 | 7 | MODULE_198 | |
| Drug | NSC-629231 | 1.16e-12 | 55 | 93 | 9 | CID000363885 | |
| Drug | N-myristoyl-rkrtlrrl | 1.31e-11 | 46 | 93 | 8 | CID003081274 | |
| Drug | Scriptaid | 1.88e-11 | 48 | 93 | 8 | CID000005186 | |
| Drug | CAS 1400-61-9 | 4.35e-11 | 53 | 93 | 8 | CID000004568 | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | H2BC11 AHI1 H2BC15 H2BC17 H2BC21 CCN1 H1-2 H1-3 H1-4 H1-5 H2BC5 | 5.42e-11 | 160 | 93 | 11 | 5364_UP |
| Drug | 5-methyl-dCTP | 5.93e-11 | 55 | 93 | 8 | CID000161376 | |
| Drug | DB08184 | 8.61e-11 | 167 | 93 | 11 | CID009547945 | |
| Drug | In-G | NCOA6 ARID4A ING2 KAT6A H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 | 1.04e-10 | 170 | 93 | 11 | CID000446054 |
| Drug | 3-tert-butylphenyl-N-methyl-carbamate | 1.14e-10 | 36 | 93 | 7 | CID000013072 | |
| Drug | SK-7041 | 1.23e-10 | 60 | 93 | 8 | CID006918714 | |
| Drug | heparin disaccharide iii-S | 1.40e-10 | 37 | 93 | 7 | CID000448838 | |
| Drug | Methylmethacrylate | 2.08e-10 | 39 | 93 | 7 | ctd:D020366 | |
| Drug | Spkk | 4.31e-10 | 43 | 93 | 7 | CID000129363 | |
| Drug | GH 5 | 6.03e-10 | 45 | 93 | 7 | CID000163897 | |
| Drug | 3-aminobenzamide | 8.46e-10 | 156 | 93 | 10 | CID000001645 | |
| Drug | belinostat | 1.31e-09 | 50 | 93 | 7 | CID006918638 | |
| Drug | C04378 | 1.59e-09 | 82 | 93 | 8 | CID000440315 | |
| Drug | AC1L1FWN | DAB2 H2BC17 H2BC21 CTCF H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 METAP2 | 2.26e-09 | 227 | 93 | 11 | CID000003425 |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.32e-09 | 173 | 93 | 10 | 3464_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | H2BC11 ARID4A H2BC17 H2BC21 CCN1 H1-0 H1-2 H1-3 H2BC5 H2BC12 | 3.05e-09 | 178 | 93 | 10 | 6220_UP |
| Drug | AC1OCADI | 3.13e-09 | 130 | 93 | 9 | CID006914639 | |
| Drug | 8-bromoguanosine | 4.37e-09 | 93 | 93 | 8 | CID000092977 | |
| Drug | polyarginine | 5.18e-09 | 95 | 93 | 8 | CID000072364 | |
| Drug | Amphoterin | 5.65e-09 | 139 | 93 | 9 | CID003496889 | |
| Drug | gold sodium thiomalate | 6.18e-09 | 62 | 93 | 7 | CID000022318 | |
| Drug | F2-b | 9.65e-09 | 66 | 93 | 7 | CID000001700 | |
| Drug | MS-275 | 1.04e-08 | 149 | 93 | 9 | CID000004261 | |
| Drug | syntide-2 | 1.62e-08 | 71 | 93 | 7 | CID005074902 | |
| Drug | sodium butyrate | KAT6A HMGB2 H2BC9 H2BC21 SEC62 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC3 H1-1 | 1.63e-08 | 344 | 93 | 12 | CID005222465 |
| Drug | Apicidin | 2.05e-08 | 113 | 93 | 8 | CID000467801 | |
| Drug | AlCl3 | 2.05e-08 | 113 | 93 | 8 | CID000024012 | |
| Drug | mustard oil | 2.20e-08 | 114 | 93 | 8 | CID000005971 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.67e-08 | 166 | 93 | 9 | 3290_UP | |
| Drug | Trapoxin B | 3.44e-08 | 79 | 93 | 7 | CID000005532 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.45e-08 | 171 | 93 | 9 | 5247_UP | |
| Drug | NaBu | 3.75e-08 | 122 | 93 | 8 | CID000052923 | |
| Drug | 5-methylcytosine | 3.99e-08 | 233 | 93 | 10 | CID000065040 | |
| Drug | butane | 4.00e-08 | 123 | 93 | 8 | CID000007843 | |
| Drug | butyrolactone I | 5.46e-08 | 128 | 93 | 8 | CID000123740 | |
| Drug | DADS | 6.54e-08 | 131 | 93 | 8 | CID000016590 | |
| Drug | AC1L9M5N | 7.36e-08 | 133 | 93 | 8 | CID000448618 | |
| Drug | chlorambucil | 7.36e-08 | 133 | 93 | 8 | CID000002708 | |
| Drug | procainamide | 8.54e-08 | 190 | 93 | 9 | CID000004913 | |
| Drug | LAQ824 | 9.96e-08 | 92 | 93 | 7 | CID006445533 | |
| Drug | NSC23766 | 1.54e-07 | 98 | 93 | 7 | CID000409805 | |
| Drug | gamma-butyrolactone | 3.01e-07 | 108 | 93 | 7 | CID000007302 | |
| Drug | CGP 41251 | 3.01e-07 | 108 | 93 | 7 | CID000104937 | |
| Drug | DNA methyltransferase inhibitor | 3.06e-07 | 160 | 93 | 8 | CID000344265 | |
| Drug | 5-aza-2'-deoxycytidine | SFRP1 ARID4A DAB2 H1-8 H2BC17 H2BC21 AEBP1 CTCF H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 | 3.08e-07 | 638 | 93 | 14 | CID000016886 |
| Drug | LBH589 | 3.20e-07 | 109 | 93 | 7 | CID006918837 | |
| Drug | gibberellin (GA | 4.06e-07 | 166 | 93 | 8 | CID000006466 | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 4.44e-07 | 168 | 93 | 8 | 2801_UP | |
| Drug | OTX015 | 4.57e-07 | 16 | 93 | 4 | ctd:C000605331 | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 5.09e-07 | 171 | 93 | 8 | 2723_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 5.56e-07 | 173 | 93 | 8 | 5612_UP | |
| Drug | A25618 | SP100 SFRP1 ING2 KAT6A DAB2 PSMC1 H2BC17 H2BC21 BRD4 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 | 5.70e-07 | 777 | 93 | 15 | CID000005562 |
| Drug | Kemptide | 7.70e-07 | 124 | 93 | 7 | CID000100074 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 9.23e-07 | 185 | 93 | 8 | 6945_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 1.08e-06 | 189 | 93 | 8 | 6649_DN | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 1.17e-06 | 191 | 93 | 8 | 7507_DN | |
| Drug | NSC611747 | 1.78e-06 | 352 | 93 | 10 | CID000002534 | |
| Drug | Berberine | 1.79e-06 | 202 | 93 | 8 | ctd:D001599 | |
| Drug | AC1L45LU | 1.99e-06 | 205 | 93 | 8 | CID000151069 | |
| Drug | ara-AC | 2.14e-06 | 279 | 93 | 9 | CID000001805 | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; HL60; HT_HG-U133A | 3.74e-06 | 157 | 93 | 7 | 1304_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; PC3; HT_HG-U133A | 3.74e-06 | 157 | 93 | 7 | 6764_UP | |
| Drug | 4-PBA | 3.85e-06 | 224 | 93 | 8 | CID000004775 | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 3.90e-06 | 158 | 93 | 7 | 5743_UP | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; HL60; HT_HG-U133A | 4.79e-06 | 163 | 93 | 7 | 2145_UP | |
| Drug | spermine | 4.84e-06 | 394 | 93 | 10 | CID000001103 | |
| Drug | BM-11 | 4.95e-06 | 28 | 93 | 4 | CID003036083 | |
| Drug | Pe v | 4.99e-06 | 164 | 93 | 7 | CID005326793 | |
| Drug | myristate | 5.06e-06 | 310 | 93 | 9 | CID000011005 | |
| Drug | gossypol | 7.88e-06 | 247 | 93 | 8 | CID000003503 | |
| Drug | E-PEG | TRIM25 ING2 KAT6A PSMC1 H2BC17 CCN1 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 | 8.48e-06 | 621 | 93 | 12 | CID000003310 |
| Drug | W7 hydrochloride | 8.61e-06 | 250 | 93 | 8 | CID000005681 | |
| Drug | spermidine | 9.39e-06 | 253 | 93 | 8 | CID000001102 | |
| Drug | SN-38 | 1.06e-05 | 184 | 93 | 7 | CID000104842 | |
| Drug | NSC351140 | 1.08e-05 | 258 | 93 | 8 | CID000002210 | |
| Drug | hydralazine | 1.14e-05 | 186 | 93 | 7 | CID000003637 | |
| Drug | zinc chloride (ZnCl2 | 1.14e-05 | 186 | 93 | 7 | CID000005727 | |
| Drug | propionate | 1.21e-05 | 262 | 93 | 8 | CID000001032 | |
| Drug | AC1Q6AQ7 | 1.22e-05 | 188 | 93 | 7 | CID000005515 | |
| Drug | sulfite | 1.22e-05 | 438 | 93 | 10 | CID000001099 | |
| Drug | arsenite | 1.25e-05 | 347 | 93 | 9 | CID000000544 | |
| Drug | cytosine | 1.29e-05 | 441 | 93 | 10 | CID000000597 | |
| Drug | MgCl2 | 1.46e-05 | 354 | 93 | 9 | CID000024584 | |
| Drug | ADP-Rib | 1.46e-05 | 269 | 93 | 8 | CID000000192 | |
| Drug | S-adenosylmethionine | 1.50e-05 | 355 | 93 | 9 | CID000001079 | |
| Drug | B on A | 2.00e-05 | 464 | 93 | 10 | CID000007104 | |
| Drug | copper | NCOA6 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 SPAG17 HMGN4 | 2.13e-05 | 571 | 93 | 11 | CID000023978 |
| Drug | Velcade (bortezomib | 2.26e-05 | 374 | 93 | 9 | CID000093860 | |
| Drug | AC1Q68Z5 | 2.89e-05 | 386 | 93 | 9 | CID000000181 | |
| Drug | vorinostat | 4.41e-05 | 314 | 93 | 8 | CID000005311 | |
| Drug | APDC | 4.82e-05 | 318 | 93 | 8 | CID000065351 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.05e-05 | 160 | 93 | 6 | 2210_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 5.41e-05 | 162 | 93 | 6 | 2658_UP | |
| Drug | Actinomycin D | 5.50e-05 | 523 | 93 | 10 | CID000002019 | |
| Drug | hydroxyurea | 7.41e-05 | 436 | 93 | 9 | CID000003657 | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; PC3; HT_HG-U133A | 8.04e-05 | 174 | 93 | 6 | 4243_UP | |
| Disease | Inguinal hernia | 1.67e-08 | 287 | 89 | 10 | HP_0000023 | |
| Disease | Childhood Medulloblastoma | 3.00e-04 | 43 | 89 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 3.00e-04 | 43 | 89 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 3.00e-04 | 43 | 89 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 3.00e-04 | 43 | 89 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 3.00e-04 | 43 | 89 | 3 | C0278876 | |
| Disease | Medulloblastoma | 4.69e-04 | 50 | 89 | 3 | C0025149 | |
| Disease | skin and soft tissue Staphylococcus aureus infection | 6.87e-04 | 13 | 89 | 2 | EFO_1001489 | |
| Disease | transferrin receptor protein 1 measurement | 8.00e-04 | 14 | 89 | 2 | EFO_0802142 | |
| Disease | venous thromboembolism | 2.72e-03 | 460 | 89 | 6 | EFO_0004286 | |
| Disease | liver iron measurement | 4.47e-03 | 33 | 89 | 2 | EFO_0010056 | |
| Disease | colon cancer (is_implicated_in) | 5.30e-03 | 36 | 89 | 2 | DOID:219 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 5.36e-03 | 702 | 89 | 7 | C0009402 | |
| Disease | glycoprotein measurement | 5.64e-03 | 119 | 89 | 3 | EFO_0004555 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVDSGPPPKRKKKKK | 661 | Q9UKF5 | |
| PLDKGGPKKKQKKKA | 631 | P29374 | |
| PAALNKPEKLKKKKK | 441 | Q8WY36 | |
| PPKPTKIKKKGVKKT | 251 | P49711 | |
| KKSKAKEPPPKKTKK | 561 | O60885 | |
| DTKPKPKKTKKKTKA | 296 | Q8N157 | |
| KGKKDKGPKVPKESL | 96 | Q8IUX7 | |
| KATKKPKEKPPKATK | 126 | Q8IUX7 | |
| VKKKKKKTNKGPAVG | 691 | Q9H5V8 | |
| KKGKKCSKTKKSPEP | 281 | O00622 | |
| PKKAASKAPTKKPKA | 126 | P07305 | |
| KKPKATPVKKAKKKL | 136 | P07305 | |
| TPVKKAKKKLAATPK | 141 | P07305 | |
| AKKKLAATPKKAKKP | 146 | P07305 | |
| KAKKPKTVKAKPVKA | 156 | P07305 | |
| KTVKAKPVKASKPKK | 161 | P07305 | |
| KPVKASKPKKAKPVK | 166 | P07305 | |
| SKPKKAKPVKPKAKS | 171 | P07305 | |
| EKPLAGKKAKKPAKA | 16 | Q02539 | |
| SKKSVKTPKKAKKPA | 146 | Q02539 | |
| SKNPKKPKTVKPKKV | 166 | Q02539 | |
| KPKTVKPKKVAKSPA | 171 | Q02539 | |
| KPKKVAKSPAKAKAV | 176 | Q02539 | |
| AKPKVKKAGGTKPKK | 116 | P16403 | |
| TKPKKPVGAAKKPKK | 126 | P16403 | |
| KKPKKAAGGATPKKS | 136 | P16403 | |
| TPKKSAKKTPKKAKK | 146 | P16403 | |
| AKSPKKAKVAKPKKA | 171 | P16403 | |
| KAVKPKAAKPKVVKP | 191 | P16403 | |
| KAAKPKVVKPKKAAP | 196 | P16403 | |
| FPGKSKKPSSKGKKK | 86 | Q9ULD4 | |
| PKKGSKKAVTKAQKK | 11 | P57053 | |
| NRKTPVEKKKPKKKS | 166 | P62834 | |
| KTKKKGQKKSGRPKK | 411 | P42696 | |
| KPQAKAAKAPPKKAK | 151 | Q14978 | |
| KVKAEPPPKKRKKWK | 1491 | Q2KHR3 | |
| KSPGIPAGAKTKKKK | 36 | Q9NYA3 | |
| PKKGSKKAVTKAQKK | 11 | Q16778 | |
| PKKGSKKAVTKAQKK | 11 | P06899 | |
| PKKGSKKAVTKAQKK | 11 | Q99877 | |
| KRAKALKGKEPPKKV | 221 | O14979 | |
| KAPSKKEKKKGPEKT | 21 | P98082 | |
| SPTKKKVVAKAKAPK | 276 | Q8IZA3 | |
| KKKKKKRGPKVQTDP | 101 | P50579 | |
| PKKGSKKAVTKAQKK | 11 | Q6DN03 | |
| PKKGSKKAVTKAQKK | 11 | Q6DRA6 | |
| KKKKQFGKKRKRIPP | 621 | Q969R5 | |
| LKPQKKGKTSPKDKK | 531 | A6NIV6 | |
| PKDKKGKKDVKGKPG | 541 | A6NIV6 | |
| AKKGKKGKKAPEPEK | 11 | Q9UKN7 | |
| KNYVPPKGDKKGKKK | 76 | P26583 | |
| KVKKAAKPSVPKVPK | 196 | Q92522 | |
| PKKGSKKAVTKAQKK | 11 | P58876 | |
| PKKGSKKAVTKAQKK | 11 | Q93079 | |
| PKKGSKKAVTKAQKK | 11 | O60814 | |
| PKKASAKKGEKLPKG | 41 | O00479 | |
| PTLNKKKKSKVKPKK | 311 | Q6AI08 | |
| KRKEKPKKDKTKGPK | 836 | Q0VF49 | |
| VAGKKPVVGKKGKKA | 371 | P36578 | |
| KGKKAAVGVKKQKKP | 381 | P36578 | |
| KSPGIPAGAKTKKKK | 36 | A6NDN3 | |
| QPPKEKKSKSAKKKK | 176 | Q9H160 | |
| PPKETPKKKKKFSFK | 81 | P49006 | |
| ANKPKKKKPPRKKKN | 911 | Q14686 | |
| LKKKKGWPKGKSRKP | 1146 | Q92794 | |
| PKKGSKKAITKAQKK | 11 | P33778 | |
| PKKGSKKAVTKAQKK | 11 | P62807 | |
| KKRAPPAPKKKQKKV | 171 | Q8N9C0 | |
| PKKGSKKAVTKAQKK | 11 | Q8N257 | |
| PKAKKAGAAKAKKPA | 121 | P16401 | |
| AKKPAGATPKKAKKA | 131 | P16401 | |
| AGAKKAVKKTPKKAK | 146 | P16401 | |
| PKKAKKPAAAGVKKV | 156 | P16401 | |
| AKSPKKAKAAAKPKK | 171 | P16401 | |
| AKPKKATKSPAKPKA | 181 | P16401 | |
| AKPKAVKPKAAKPKA | 191 | P16401 | |
| VKPKAAKPKAAKPKA | 196 | P16401 | |
| AKPKAAKPKAAKPKA | 201 | P16401 | |
| AKPKAAKPKAAKAKK | 206 | P16401 | |
| PKKGSKKAVTKAQKK | 11 | Q99880 | |
| PKKGSKKAVTKAQKK | 11 | P23527 | |
| KSPGIPAGAKTKKKK | 36 | A6NDK9 | |
| APKKKKNKGKKGLEP | 151 | Q9GZR7 | |
| KKTKPPALTKKHKKK | 536 | Q53TQ3 | |
| KSPGIPAGAKTKKKK | 36 | P0CG33 | |
| AKAKKPAGAAKKPKK | 126 | P10412 | |
| TPKKSAKKTPKKAKK | 146 | P10412 | |
| KSPKKAKAAKPKKAP | 171 | P10412 | |
| AKAAKPKKAPKSPAK | 176 | P10412 | |
| PKKAPKSPAKAKAVK | 181 | P10412 | |
| PKAAKPKTAKPKAAK | 196 | P10412 | |
| PKTAKPKAAKPKKAA | 201 | P10412 | |
| AKKPKKVAGAATPKK | 136 | P16402 | |
| ATPKKSIKKTPKKVK | 146 | P16402 | |
| PKKVKKPATAAGTKK | 156 | P16402 | |
| AKAKAPKPKAAKPKS | 191 | P16402 | |
| AKPKSGKPKVTKAKK | 201 | P16402 | |
| GKPKVTKAKKAAPKK | 206 | P16402 | |
| TPGKKKKKKLGPKKE | 111 | Q14839 | |
| LPGKKKKKTKAPPLS | 51 | Q8IY37 | |
| KKKAKKGQLTKKKSP | 256 | Q8NCQ7 | |
| NKKKKNKKKKSPVPV | 571 | Q32MZ4 | |
| KKKKPKKDSIGSKSK | 401 | Q15542 | |
| SSSASPPPKKKKKKK | 161 | A6NNA2 | |
| PKKKTTKVAKKGKAV | 31 | Q9NNX9 | |
| RSPTPKQKKKKKKKD | 181 | Q9UQ35 | |
| PKKKTTKVAKKGKAV | 31 | Q9H321 | |
| KKKKYAKEAWPGKKP | 331 | Q12972 | |
| EVPKSGKGKKKSKPV | 76 | P62316 | |
| AKPGKPKGKKKLSSV | 91 | Q96BN2 | |
| MPKGKKAKGKKVAPA | 1 | P62424 | |
| KKKTKSSKPSKPEKD | 1121 | P35251 | |
| KKTPGKKTGKKKEKD | 466 | A6NCM1 | |
| AGPPKKKRKKTQKKF | 41 | O75683 | |
| KKFFKTRKPKPKKPT | 326 | Q8WUT9 | |
| KKKKTKGPDAASKLP | 36 | P62191 | |
| KKKKGKLPKNYDPKV | 556 | O76094 | |
| GDKKIVPKKKKPLKL | 221 | Q8N474 | |
| KPLKLGPIKKKDLKK | 231 | Q8N474 | |
| KAKGKIKGKEKPKES | 1176 | Q6Q759 | |
| KSKKKNKGPIAGKSK | 546 | Q8WXI2 | |
| LVKPKKGHSGKKPLK | 131 | Q5HYK9 | |
| PDKKALKKKGTPKGA | 231 | O00294 | |
| PKKKTTKVAKKGKAV | 31 | Q9H322 | |
| KVKKGNLKAKKPKKG | 26 | Q02878 | |
| NLKAKKPKKGKPHCS | 31 | Q02878 | |
| PGTPKKKETKKKFKL | 156 | Q99442 | |
| GKAKPKKQSKKKVPF | 56 | Q7RTY8 | |
| KPKKTKVKAKAGAKK | 896 | Q9H7N4 | |
| KKVSKEEKKSKKPPP | 381 | Q14258 | |
| KGEKKKKFKDPNAPK | 756 | P23497 | |
| YSPSPVKKKKKKSSK | 126 | A7MD48 | |
| QPKAKPKKKKKPTLR | 736 | Q8TEQ6 | |
| SKKKKPLKKKPTPVL | 526 | Q9UGP8 | |
| CKKAGPKPKKAKDAG | 116 | O15318 | |
| KKPKGDHKKTPGKKV | 846 | Q96AE7 | |
| PKKKTTKVAKKGKAV | 31 | Q9H320 | |
| GGKKKPLKQPKKQAK | 6 | Q9Y2S6 | |
| PFGKKTKKEKKEKGK | 131 | Q3YBR2 | |
| GKKQKAPKKRKKKDP | 206 | O94842 | |
| MAPKKKGKKGKAKGT | 1 | O95995 |